idx	Proteomics_Aliquot_ID	Proteomics_Participant_ID	Proteomics_TMT_batch	Proteomics_TMT_plex	Proteomics_TMT_channel	Proteomics_Parent_Sample_IDs	Proteomics_Tumor_normal	Proteomics_OCT	WXS_patient_id	WXS_Tumor_sample_id	WXS_Tumor_file	WXS_Tumor_UUID	WXS_Tumor_type	WXS_Normal_sample_id	WXS_Normal_file	WXS_Normal_UUID	WXS_Normal_type	RNAseq_sample_id	RNAseq_patient_id	RNAseq_sample_type	RNAseq_UUID_R1	RNAseq_filename_R1	RNAseq_UUID_R2	RNAseq_filename_R2	methylation_sample_id	Histologic_Grade_(FIGO)	Histologic_Type	Num_full_term_pregnancies	Tumor_Size_(cm)	FIGO_stage	Myometrial_invasion_Specify	tumor_Stage_Pathological	Diabetes	BMI	LVSI	Endo_S1G1G2_LVSI	Age	CIBERSORT-T_cells_CD4_memory_resting	CIBERSORT-Dendritic_cells_resting	CIBERSORT-T_cells_regulatory_(Tregs)	CIBERSORT-Neutrophils	CIBERSORT-Macrophages_M1	CIBERSORT-Macrophages_M2	CIBERSORT-Dendritic_cells_activated	CIBERSORT-Monocytes	CIBERSORT-Macrophages_M0	CIBERSORT-B_cells_naive	CIBERSORT-NK_cells_activated	CIBERSORT-T_cells_CD4_memory_activated	CIBERSORT-B_cells_memory	CIBERSORT-Plasma_cells	CIBERSORT-T_cells_follicular_helper	CIBERSORT-T_cells_CD8	CIBERSORT-T_cells_CD4_naive	CIBERSORT-Absolute_score	CIBERSORT-Eosinophils	CIBERSORT-T_cells_gamma_delta	CIBERSORT-NK_cells_resting	CIBERSORT-Mast_cells_resting	CIBERSORT-Mast_cells_activated	EPIC-Bcells	EPIC-Endothelial	EPIC-CAFs	EPIC-otherCells	EPIC-CD8_Tcells	EPIC-NKcells	EPIC-Macrophages	EPIC-CD4_Tcells	ESTIMATE-ImmuneScore	ESTIMATE-StromalScore	ESTIMATE-ESTIMATEScore	PR_PGR	ER_ESR1	PI3K_RICTOR	PI3K_PIK3R1	PI3K_AKT3	PI3K_MTOR	PI3K_PIK3CB	PI3K_PPP2R1A	PI3K_TSC2	PI3K_PIK3R2	PI3K_PTEN	PI3K_PI3K_pathway	PI3K_TSC1	PI3K_PIK3CA	TP53_ATM	TP53_RPS6KA3	TP53_TP53	TP53_TP53_pathway	HRD_BRCA1_or_BRCA2	HRD_BRCA2	HRD_BRCA1	MSI	POLE_EDM_status	Histologic_Type_corrected	Tumor_purity
S001	CPT0001460012	C3L-00006	2	5	128N	C3L-00006-01	Tumor	No	C3L-00006	CPT0001460007	CPT0001460007.WholeExome.RP-1303.bam	b821093d-2551-4327-96d5-07bc91c6d8aa	Primary_Tumor	CPT0000120163	CPT0000120163.WholeExome.RP-1303.bam	cc3a2843-4c09-4270-a0be-62a0dfccce7f	Blood_Derived_Normal	CPT0001460164	C3L-00006	Primary Tumor	8a1efc47-1c29-417f-a425-cdbd09565dcb	170802_UNC31-K00269_0072_AHK3GVBBXX_TAGCTT_S17_L005_R1_001.fastq.gz	8c3fe9b7-7acd-4867-8d9c-a8e5d1516eda	170802_UNC31-K00269_0072_AHK3GVBBXX_TAGCTT_S17_L005_R2_001.fastq.gz	C3L-00006	FIGO grade 1	Endometrioid carcinoma	1	2.9	IA	under 50 %	Stage I	No	38.88	1	1	64	0.088247615	0	0	0.00967535	0.047057934	0.072523873	0.00612096	0	0.024896194	0.010443511	0.020942068	0	0	0.017867521	0.035408717	0.036816257	0	0.37	0	0	0	0	0	0.004595748	0.047247678	0.045125791	0.79012722	0.034381469	6.39E-10	0.002878929	0.075643165	4885.608881	2821.088429	7706.69731	-0.0447	0.565	0	0	0	0	0	1	0	0	1	1	1	1	0	0	1	1	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S002	CPT0001300009	C3L-00008	4	16	130N	C3L-00008-01	Tumor	No	C3L-00008	CPT0001300005	CPT0001300005.WholeExome.RP-1303.bam	d38806cb-be68-4219-ac60-2381e2ce6d0f	Primary_Tumor	CPT0000080163	CPT0000080163.WholeExome.RP-1303.bam	185b6084-2a62-4469-8aa2-86a4e8601300	Blood_Derived_Normal	CPT0001300164	C3L-00008	Primary Tumor	555725e8-cba5-4676-9b0a-80100cbf9f47	170802_UNC31-K00269_0072_AHK3GVBBXX_GGCTAC_S22_L007_R1_001.fastq.gz	15235b12-b67a-4678-acc4-ed03d642bd5e	170802_UNC31-K00269_0072_AHK3GVBBXX_GGCTAC_S22_L007_R2_001.fastq.gz	C3L-00008	FIGO grade 1	Endometrioid carcinoma	1	3.5	IA	under 50 %	Stage IV	No	39.76	0	0	58	0.026435753	0.010407182	0	0	0.00394293	0.027211297	0.007160341	0.00385161	0.016040522	0.004411131	0.004934448	0	0	0.00176099	0.014944149	0.002130758	0	0.15	0.011681456	0	0	0	0.015087431	0.005666428	0.056081262	0.056677626	0.738161488	0.041562969	4.15E-09	0.001627258	0.100222966	3632.199987	2714.248104	6346.448091	0.0375	-0.367	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S003	CPT0001420009	C3L-00032	1	2	131	C3L-00032-01	Tumor	No	C3L-00032	CPT0001420005	CPT0001420005.WholeExome.RP-1303.bam	f7c2228a-b4cd-42b4-b355-ce777d9c54be	Primary_Tumor	CPT0000110163	CPT0000110163.WholeExome.RP-1303.bam	14ff5c48-84a3-4fb3-8d43-f148bf19c91a	Blood_Derived_Normal	CPT0001420164	C3L-00032	Primary Tumor	9ae968f3-691d-4db3-9977-1ab3e5af9085	170802_UNC31-K00269_0072_AHK3GVBBXX_GTCCGC_S18_L005_R1_001.fastq.gz	423b6b09-02aa-4f47-9241-f75c1dad1161	170802_UNC31-K00269_0072_AHK3GVBBXX_GTCCGC_S18_L005_R2_001.fastq.gz	C3L-00032	FIGO grade 2	Endometrioid carcinoma	4 or more	4.5	IA	under 50 %	Stage I	Yes	51.19	0	0	50	0.217047308	0.021836951	0	0.094933366	0.020499422	0.049193367	0.039683645	0	0.122233997	0.039852399	0	0	0	0.050305497	0.001314347	0.043745478	0	0.78	0.027104312	0	0.018425297	0	0.033824616	0.006418323	0.050682921	0.067375618	0.712040724	0.031354942	2.10E-10	0.004971567	0.127155905	6602.912323	3856.501277	10459.4136	-0.5	-0.471	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S004	CPT0001140003	C3L-00090	3	12	129C	C3L-00090-01	Tumor	No	C3L-00090	CPT0001140005	CPT0001140005.WholeExome.RP-1303.bam	f45d244b-6f8e-422e-b66a-ebab6c288193	Primary_Tumor	CPT0000040163	CPT0000040163.WholeExome.RP-1303.bam	4d0d66b8-65d9-40d4-894b-6cf9bbead21b	Blood_Derived_Normal	CPT0001140164	C3L-00090	Primary Tumor	8ce5618d-9ff6-40f9-aeea-8d8e1633ae38	170802_UNC31-K00269_0072_AHK3GVBBXX_GAGTGG_S10_L003_R1_001.fastq.gz	06d3fd4a-a623-4146-8500-4f1f17235253	170802_UNC31-K00269_0072_AHK3GVBBXX_GAGTGG_S10_L003_R2_001.fastq.gz	C3L-00090	FIGO grade 2	Endometrioid carcinoma	4 or more	3.5	IA	under 50 %	Stage I	Yes	32.69	0	0	75	0.06169803	0	0.022737675	0	0.018807855	0.122544366	0.0041831	0.002542568	0	0	0.014684549	0	0.019078676	0.007199854	0	0.047075193	0	0.39	0.0009	0.002598418	0	0.065981557	0	0.005577885	0.058249827	0.060593928	0.715367914	0.044365306	9.84E-10	0.003754992	0.112090146	4462.910274	3012.556593	7475.466867	-0.129	-0.0456	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S005	CPT0000980012	C3L-00098	4	14	129N	C3L-00098-02	Tumor	No	C3L-00098	CPT0000980005	CPT0000980005.WholeExome.RP-1303.bam	9481cd37-140a-458d-980e-a06d3bc2f479	Primary_Tumor	CPT0003930002	CPT0003930002.WholeExome.RP-1303.bam	cf61e0c2-8026-4223-a45e-c92d7b52b31c	Blood_Derived_Normal	CPT0000980008	C3L-00098	Primary Tumor	31252ba9-e052-4b77-809a-f936379ae00c	170802_UNC31-K00269_0072_AHK3GVBBXX_TTAGGC_S8_L002_R1_001.fastq.gz	23be22ae-de50-4d74-a7c0-c890adbc662a	170802_UNC31-K00269_0072_AHK3GVBBXX_TTAGGC_S8_L002_R2_001.fastq.gz	C3L-00098	NA	NA	2	6	IA	under 50 %	Stage I	No	20.28	NA	NA	63	0.015101252	0	0	0	0.064099852	0.140338468	0	0	0.054263627	0.005773262	0.02318389	0.026119631	0	0.027627049	0.011140644	0.050190166	0	0.43	0	0.012162159	0	0	0	0.003088213	0.063943075	0.014328871	0.816145315	0.031658353	8.69E-09	0.007304327	0.063531838	6545.943147	1717.74787	8263.691016	-2.4	-2.04	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	NA	normal
S006	CPT0000730011	C3L-00136	4	16	129C	C3L-00136-03	Tumor	No	C3L-00136	CPT0000730008	CPT0000730008.WholeExome.RP-1303.bam	6f7512c3-23ab-42ae-855c-c27bc12b1304	Primary_Tumor	CPT0003860002	CPT0003860002.WholeExome.RP-1303.bam	d837ac33-bb34-43ee-9b1e-4474ed7a2e11	Blood_Derived_Normal	CPT0000730005	C3L-00136	Primary Tumor	df0e2942-c702-4135-81a0-fbec4439d753	170818_UNC32-K00270_0050_AHL2FHBBXX_GTCCGC_S10_L003_R1_001.fastq.gz	4e1ad404-4646-4828-91b9-e3c35a4ce505	170818_UNC32-K00270_0050_AHL2FHBBXX_GTCCGC_S10_L003_R2_001.fastq.gz	C3L-00136	FIGO grade 1	Endometrioid carcinoma	3	4.5	IA	under 50 %	Stage I	No	55.67	0	0	50	0.218447078	0.00817583	0	0	0.012830509	0.145650337	0.012429489	0.041004139	0.027346769	0.001059623	0.014546171	0	0	0.012292451	0.014378883	0.089036423	0	0.9	0.006304285	0	0.084425262	0.21207275	0	0.001629109	0.114858814	0.064998151	0.634700169	0.006508822	9.76E-10	0.003170654	0.174134279	5622.138932	3414.419984	9036.558917	-0.724	-1.05	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S007	CPT0002010011	C3L-00137	4	15	130N	C3L-00137-02	Tumor	No	C3L-00137	CPT0002010008	CPT0002010008.WholeExome.RP-1303.bam	7c411bd7-7536-4f0b-9ae9-0522c5888e35	Primary_Tumor	CPT0003870002	CPT0003870002.WholeExome.RP-1303.bam	3df85f07-ff4f-467f-aba1-12c26b93d210	Blood_Derived_Normal	CPT0002010005	C3L-00137	Primary Tumor	8fcdd6a1-a7c7-41b5-8b44-e41f2237b236	170818_UNC32-K00270_0050_AHL2FHBBXX_GTGAAA_S12_L003_R1_001.fastq.gz	2bea607d-6eb2-4583-90d7-7823a3d8a572	170818_UNC32-K00270_0050_AHL2FHBBXX_GTGAAA_S12_L003_R2_001.fastq.gz	C3L-00137	FIGO grade 1	Endometrioid carcinoma	2	5	IA	under 50 %	Stage I	No	25.68	1	1	60	0.096159419	0	0	0	0.006238274	0.066621604	0.015480802	0.019246682	0	0.052107498	0.027957379	0	0	0.006136476	0.058437763	0.01781162	0	0.44	0.024383635	0	0	0	0.049418849	0.004052783	0.056644142	0.09190801	0.73356776	0.042667198	8.13E-09	0.001135568	0.07002453	2928.488048	2309.012756	5237.500804	-0.555	0.7	0	1	0	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S008	CPT0001850012	C3L-00139	3	11	130N	C3L-00139-01	Tumor	No	C3L-00139	CPT0001850005	CPT0001850005.WholeExome.RP-1303.bam	b38279e5-8876-4c84-a1eb-7a4c215c5b63	Primary_Tumor	CPT0003950002	CPT0003950002.WholeExome.RP-1303.bam	0b6c6926-2144-4a6d-adf3-8e91775ab83c	Blood_Derived_Normal	CPT0001850008	C3L-00139	Primary Tumor	7785d5a1-a60d-41f9-86f3-e4ebc100704c	170802_UNC31-K00269_0072_AHK3GVBBXX_CAGATC_S1_L001_R1_001.fastq.gz	90ced367-0342-4739-93b2-4b1a4af800c4	170802_UNC31-K00269_0072_AHK3GVBBXX_CAGATC_S1_L001_R2_001.fastq.gz	C3L-00139	NA	Serous carcinoma	4 or more	4	IIIA	50 % or more	Stage III	No	21.57	1	NA	83	0.101975277	0	0.016090453	0	0.053001228	0.035774299	0.009007116	0.012905363	0.074245364	0	0.010194706	0	0	0.00615282	0.060458172	0.017771978	0	0.53	0.010748036	0.021748457	0	0.099926731	0	0.003577571	0.067883558	0.067769323	0.761783675	0.032434667	4.04E-09	0.001420519	0.065130682	2838.299899	2515.79784	5354.097739	-2	-1.11	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S009	CPT0001910016	C3L-00143	4	14	130C	C3L-00143-01	Tumor	No	C3L-00143	CPT0001910012	CPT0001910012.WholeExome.RP-1303.bam	2b9d0ef1-2613-4585-947b-bda648d9c758	Primary_Tumor	CPT0003970002	CPT0003970002.WholeExome.RP-1303.bam	22657d1a-e86c-42ab-8d78-96ec68d47f81	Blood_Derived_Normal	CPT0001910008	C3L-00143	Primary Tumor	6412838b-2f70-4b14-a6ee-3c7baca09fb0	170802_UNC31-K00269_0072_AHK3GVBBXX_ACTTGA_S4_L001_R1_001.fastq.gz	5d0a26e0-2739-4f38-9350-c685b44911d3	170802_UNC31-K00269_0072_AHK3GVBBXX_ACTTGA_S4_L001_R2_001.fastq.gz	C3L-00143	FIGO grade 1	Endometrioid carcinoma	2	5.2	IA	Not identified	Stage I	Yes	34.26	0	0	69	0.257694874	0.061026835	0	0	0.091911576	0.352506586	0	0	0.079259476	0	0.017594418	0.002504556	0	0.034349671	0.10551234	0.305302969	0	1.36	0	0.030562897	0	0.021773803	0	0.004179295	0.044993308	0.075393304	0.655581026	0.034775754	3.74E-07	0.009247814	0.175829124	8463.786011	4181.251111	12645.03712	-1.39	-0.714	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S010	CPT0002630003	C3L-00145	3	9	131	C3L-00145-02	Tumor	No	C3L-00145	CPT0002630009	CPT0002630009.WholeExome.RP-1303.bam	e636078c-c9d4-4b0f-8a07-7bd845ea72e3	Primary_Tumor	CPT0007990002	CPT0007990002.WholeExome.RP-1303.bam	723c54f1-5177-40a6-bc94-db897dcafbb9	Blood_Derived_Normal	CPT0002630006	C3L-00145	Primary Tumor	1f5e3577-dbc5-46f7-8615-86887337a97e	170823_UNC31-K00269_0075_AHLCW5BBXX_GAGTGG_S19_L005_R1_001.fastq.gz	1c7f3fd1-e321-45b0-8e70-7ecad29c0558	170823_UNC31-K00269_0075_AHLCW5BBXX_GAGTGG_S19_L005_R2_001.fastq.gz	C3L-00145	FIGO grade 1	Endometrioid carcinoma	3	4.7	IA	under 50 %	Stage I	Yes	36.57	0	0	59	0.215617674	0.033059137	0	0.006120479	0.023867009	0.122295409	0	0.045689566	0.063456552	0.005885269	0.060977392	0	0	0.0006	0.072989693	0.016694075	0	0.72	0.010365772	0	0	0.042382678	0	0.004218625	0.110137007	0.159679699	0.583083916	0.042677677	4.99E-09	0.003454382	0.096748688	5269.577209	4669.852221	9939.42943	0.454	-0.128	0	1	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S011	CPT0002080011	C3L-00156	4	15	129N	C3L-00156-02	Tumor	No	C3L-00156	CPT0002080008	CPT0002080008.WholeExome.RP-1303.bam	48422f89-52d1-4a5c-b54d-80e512c1ab00	Primary_Tumor	CPT0004340002	CPT0004340002.WholeExome.RP-1303.bam	8df40c1d-ff3b-4889-aace-1174a97a7991	Blood_Derived_Normal	CPT0002080005	C3L-00156	Primary Tumor	e1abab26-3582-4e7c-bbea-7cadbd0e36e5	170818_UNC32-K00270_0050_AHL2FHBBXX_GTGGCC_S16_L004_R1_001.fastq.gz	b92610bf-9bcd-4f26-948d-448f963586de	170818_UNC32-K00270_0050_AHL2FHBBXX_GTGGCC_S16_L004_R2_001.fastq.gz	C3L-00156	FIGO grade 1	Endometrioid carcinoma	2	2.2	IA	under 50 %	Stage I	Yes	27.83	0	0	56	0.180804762	0	0.011980289	0.024388609	0.006664382	0.151204409	0.022078706	0.0003	0.128991522	0	0.014532283	0	0.015477154	0.050717552	0.010317116	0.0004	0	0.67	0	0	0.033211036	0	0.018873801	0.005791063	0.047452551	0.028713248	0.752621136	0.035670588	5.28E-09	0.00692925	0.122822159	5850.431589	2304.797045	8155.228634	-0.233	0.549	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	1	0	1	MSS	Mutated	Endometrioid carcinoma	normal
S012	CPT0002560003	C3L-00157	4	13	130C	C3L-00157-02	Tumor	No	C3L-00157	CPT0002560009	CPT0002560009.WholeExome.RP-1303.bam	1f04632b-6bf3-477f-b006-7bbad3ca9995	Primary_Tumor	CPT0008040002	CPT0008040002.WholeExome.RP-1303.bam	19057807-4b23-40a5-97bc-6dc121ea348f	Blood_Derived_Normal	CPT0002560006	C3L-00157	Primary Tumor	ea887db4-6dcb-4e75-b57f-5a0211fb4ba6	170823_UNC31-K00269_0075_AHLCW5BBXX_CGTACG_S17_L005_R1_001.fastq.gz	9dd491c3-794c-4f2d-8010-512c90360b1b	170823_UNC31-K00269_0075_AHLCW5BBXX_CGTACG_S17_L005_R2_001.fastq.gz	C3L-00157	NA	NA	3	4.2	IIIC2	under 50 %	Stage III	No	34.84	1	NA	60	0.027412253	0	0.001802197	0.069234075	0.009263415	0.080331073	0.05295342	0.030421378	0.00561744	0	0.016747742	0	0	0.021917773	0.017302047	0.002189731	0	0.47	0	0	0	0	0.134807458	0.004931836	0.089019671	0.008916274	0.771457457	0.02297888	1.52E-10	0.005064803	0.097631079	6285.433874	2212.345792	8497.779666	-2.13	-1.84	0	1	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	MSS	WT	NA	normal
S013	CPT0070380004	C3L-00161	4	13	131	"C3L-00161-01,C3L-00161-02"	Tumor	No	C3L-00161	CPT0070380007	CPT0070380007.WholeExome.RP-1303.bam	6d9960f6-caae-4a5d-a9c2-b6307c9c6dba	Primary_Tumor	CPT0070970002	CPT0070970002.WholeExome.RP-1303.bam	b771d847-25d3-4767-877c-c88eedf7a1ee	Blood_Derived_Normal	CPT0070380010	C3L-00161	Primary Tumor	9e12b685-c46a-431b-bb9e-a90c6f7892ee	170830_UNC31-K00269_0078_AHLCVMBBXX_CGATGT_S6_L008_R1_001.fastq.gz	787253e0-0877-4bfa-98f5-9a258f8e1b57	170830_UNC31-K00269_0078_AHLCVMBBXX_CGATGT_S6_L008_R2_001.fastq.gz	C3L-00161	FIGO grade 2	Endometrioid carcinoma	2	7	IB	50 % or more	Stage I	No	68.39	1	1	46	0.072129432	0.012365358	0.026782261	0.020368787	0.056281696	0.117348345	0	0.021205627	0.062962959	0	0	0	0	0.029774138	0.077566594	0.23977877	0	0.91	0	0	0.067142743	0.106293289	0	0.005614163	0.105438711	0.097078048	0.640998702	0.034682381	3.03E-09	0.002562586	0.113625405	5255.761765	2869.70182	8125.463586	-1.85	-0.992	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	1	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S014	CPT0002130003	C3L-00356	3	11	129C	C3L-00356-01	Tumor	No	C3L-00356	CPT0002130009	CPT0002130009.WholeExome.RP-1303.bam	26d52a87-1615-499a-8ffc-16729ea129b8	Primary_Tumor	CPT0004350002	CPT0004350002.WholeExome.RP-1303.bam	1a9a81f1-d4f9-4db8-803f-8257efa63abb	Blood_Derived_Normal	RNAseq_C3L-00356_primary_tumor	C3L-00356	Primary Tumor	4b2a33c2-3d9a-405c-9d10-049bed615f1d	171011_UNC31-K00269_0086_AHLJLCBBXX_CGATGT_S11_L004_R1_001.fastq.gz	2e91202d-2403-4619-8111-5f26fdf879b1	171011_UNC31-K00269_0086_AHLJLCBBXX_CGATGT_S11_L004_R2_001.fastq.gz	C3L-00356	NA	Serous carcinoma	2	3.9	IA	under 50 %	Stage I	No	25.37	1	NA	73	0.027481813	0	0	0.001492271	0.022855717	0.094933198	0.036388646	0	0.128290373	0.024455326	0.054428947	0	0	0.06845052	0.0549426	0.02094494	0	0.55	0.008005031	0	0	0.007330618	0	0.005414938	0.044537714	0.025758874	0.824284054	0.027960938	5.19E-10	0.001488506	0.070554976	3256.99141	1945.541934	5202.533343	-2.21	-1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S015	CPT0002210011	C3L-00358	1	3	130N	C3L-00358-01	Tumor	No	C3L-00358	CPT0002210008	CPT0002210008.WholeExome.RP-1303.bam	768ceeea-3dfe-4365-81f8-25219f36a8de	Primary_Tumor	CPT0004360002	CPT0004360002.WholeExome.RP-1303.bam	4a96af62-483c-4bbc-bb86-eb38f5d37251	Blood_Derived_Normal	CPT0002210005	C3L-00358	Primary Tumor	9cb3b6ce-7b2a-4225-b0e7-d32d47171740	170818_UNC32-K00270_0050_AHL2FHBBXX_GTTTCG_S2_L001_R1_001.fastq.gz	e9a087df-10b2-498e-90d3-cd60747088b8	170818_UNC32-K00270_0050_AHL2FHBBXX_GTTTCG_S2_L001_R2_001.fastq.gz	C3L-00358	NA	Serous carcinoma	NA	4.5	IB	50 % or more	Stage I	No	26.22	1	NA	90	0.136319654	0	0	0.006842302	0.092353708	0.213796665	0	0	0.102629415	0.0002	0.081825121	0	0	0.087616998	0.016860233	0.048920734	0	0.86	0.0003	0	0	0	0.07237302	0.005182084	0.04257597	0.022440994	0.799832446	0.018651113	1.49E-10	0.00569926	0.105618133	6074.369909	2379.6735	8454.043409	-2.92	-1.31	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S016	CPT0002430011	C3L-00361	1	2	127C	C3L-00361-01	Tumor	No	C3L-00361	CPT0002430008	CPT0002430008.WholeExome.RP-1303.bam	ada10dfa-45ec-42c5-94ef-f38364736db2	Primary_Tumor	CPT0004400002	CPT0004400002.WholeExome.RP-1303.bam	78abd9b6-8c68-4ddc-8216-1725bb3928a6	Blood_Derived_Normal	CPT0002430005	C3L-00361	Primary Tumor	d1c64f6f-aa85-463a-8773-69513cad82a7	170802_UNC31-K00269_0072_AHK3GVBBXX_ACTGAT_S12_L004_R1_001.fastq.gz	c0cbd504-5d93-4f9d-bb5a-1cbe602f2a3d	170802_UNC31-K00269_0072_AHK3GVBBXX_ACTGAT_S12_L004_R2_001.fastq.gz	C3L-00361	FIGO grade 1	Endometrioid carcinoma	None	2.7	IA	Not identified	Stage I	Yes	42.98	0	0	64	0.095277213	0.0001	0.015668239	0	0.01282946	0.058647987	0.009461798	0.004718605	0.007085054	0.005639499	0.002681846	0	0	0.022842137	0.006606719	0.029908963	0	0.3	0.0007	0	0.0001	0.027745052	0	0.005114234	0.062030244	0.025807817	0.776641607	0.037330484	6.77E-10	0.000940909	0.092134705	2936.879453	613.0876971	3549.96715	0.363	0.12	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S017	CPT0002500011	C3L-00362	2	5	130N	C3L-00362-02	Tumor	No	C3L-00362	CPT0002500008	CPT0002500008.WholeExome.RP-1303.bam	da57cb9d-9259-4263-85d9-c3289cd1e2d6	Primary_Tumor	CPT0002850002	CPT0002850002.WholeExome.RP-1303.bam	cab67bf8-4e1d-4b29-a729-5de136ec0ae3	Blood_Derived_Normal	CPT0002500005	C3L-00362	Primary Tumor	638dd879-a5ee-437c-9f30-c97dcfa19a09	170802_UNC31-K00269_0072_AHK3GVBBXX_ATTCCT_S6_L004_R1_001.fastq.gz	a02f460b-1cbd-4c92-a5ef-9928088c8c1e	170802_UNC31-K00269_0072_AHK3GVBBXX_ATTCCT_S6_L004_R2_001.fastq.gz	C3L-00362	FIGO grade 1	Endometrioid carcinoma	None	13.5	IA	Not identified	Stage I	Yes	55.86	0	0	38	0.158299126	0.030543531	0.028332406	0.018422424	0	0.06641301	0.032192268	0.046614126	0.052890205	0.028168355	0.018869097	0	0	0.008908075	0.027016898	0.05901444	0	0.61	0	0	0	0.034316037	0	0.00332298	0.07238533	0.200220933	0.586907637	0.040712363	2.86E-09	0.00133655	0.095114204	3924.864459	2953.951139	6878.815598	0.463	-0.303	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S018	CPT0009980003	C3L-00413	4	13	130N	C3L-00413-01	Tumor	No	C3L-00413	CPT0009980006	CPT0009980006.WholeExome.RP-1303.bam	acc3ff7e-787d-4a13-bb9d-28932a5ca8bb	Primary_Tumor	CPT0019850002	CPT0019850002.WholeExome.RP-1303.bam	ab051c87-a968-4d29-95ee-19a3f915f967	Blood_Derived_Normal	CPT0009980009	C3L-00413	Primary Tumor	e46aae2a-0162-443c-9f2d-7f95cd2f132e	170818_UNC32-K00270_0051_BHLCCHBBXX_GTGAAA_S1_L006_R1_001.fastq.gz	05b8da1e-d495-4023-9aca-b71417350ee1	170818_UNC32-K00270_0051_BHLCCHBBXX_GTGAAA_S1_L006_R2_001.fastq.gz	C3L-00413	FIGO grade 1	Endometrioid carcinoma	3	3.2	II	under 50 %	Stage II	No	42.19	0	NA	60	0.104674412	0	0	0.01725032	0	0.022231967	0.042889981	0.033466742	0.048188695	0.012463677	0	0	0	0.001624051	0.060904492	0	0	0.41	0.018264584	0	0.029287744	0	0.018753335	0.002976646	0.074618826	0.032530637	0.739692551	0.076101921	1.17E-09	0.00116644	0.072912978	3696.358111	1184.03053	4880.388642	-2	-1.62	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S019	CPT0007100003	C3L-00449	2	5	131	C3L-00449-01	Tumor	No	C3L-00449	CPT0007100009	CPT0007100009.WholeExome.RP-1303.bam	ca52d893-7198-48a9-ae84-3b1a48b4f9af	Primary_Tumor	CPT0002770002	CPT0002770002.WholeExome.RP-1303.bam	8e1f0839-24bd-4c64-b5e8-0293806b40d1	Blood_Derived_Normal	CPT0007100006	C3L-00449	Primary Tumor	f77c5bff-f9df-4a57-a2e9-391fcd5a6ba2	170823_UNC31-K00269_0075_AHLCW5BBXX_CGATGT_S16_L004_R1_001.fastq.gz	1faa1af4-b72b-4267-a86a-893fa2f67d7f	170823_UNC31-K00269_0075_AHLCW5BBXX_CGATGT_S16_L004_R2_001.fastq.gz	C3L-00449	FIGO grade 2	Endometrioid carcinoma	None	7	IA	under 50 %	Stage I	No	27.82	0	0	59	0.284732939	0.011092339	0	0.137670181	0.052425878	0.154422067	0.028793179	0	0.027789143	0.011222617	0.009243439	0	0	0.051383493	0.052863572	0.061136375	0	0.93	0	0	0	0.047224779	0	0.005195016	0.132518871	0.103207263	0.583354645	0.035558676	3.95E-09	0.003291385	0.13687414	6698.972556	5176.758433	11875.73099	-0.899	-0.403	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S020	CPT0063250003	C3L-00563	3	11	128N	C3L-00563-03	Tumor	No	C3L-00563	CPT0063250009	CPT0063250009.WholeExome.RP-1303.bam	b420d0ad-d133-4c1a-8506-5dffabc3e722	Primary_Tumor	CPT0065230002	CPT0065230002.WholeExome.RP-1303.bam	448749b6-0e8b-453a-9ba9-5a1cc5e29180	Blood_Derived_Normal	CPT0063250006	C3L-00563	Primary Tumor	8b076b0a-e1a0-4215-ab01-2aa7e0a0d947	170830_UNC31-K00269_0078_AHLCVMBBXX_TGACCA_S7_L002_R1_001.fastq.gz	9c892a88-3d18-4757-8c0c-ae75966102c7	170830_UNC31-K00269_0078_AHLCVMBBXX_TGACCA_S7_L002_R2_001.fastq.gz	C3L-00563	FIGO grade 1	Endometrioid carcinoma	1	3	IA	under 50 %	Stage I	Yes	34.72	0	0	62	0.107587815	0.001049951	0	0	0.012564144	0.0008	0.004345187	0.018172299	0.043837507	0	0.016213555	0.009782414	0.014642819	0.028840788	0	0.087713967	0	0.37	0.007794239	0	0	0.016645745	0	0.005543654	0.087109023	0.017993074	0.751892225	0.050296678	1.95E-10	0.001089022	0.086076324	3523.379962	864.2241924	4387.604155	1.38	0.371	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S021	CPT0023630003	C3L-00586	2	6	129C	C3L-00586-03	Tumor	No	C3L-00586	CPT0023630006	CPT0023630006.WholeExome.RP-1303.bam	785195c2-a137-4e95-8edc-3a97b61a1086	Primary_Tumor	CPT0024590002	CPT0024590002.WholeExome.RP-1303.bam	e36f3c86-e8e1-4391-92b7-e14d1e29a5f9	Blood_Derived_Normal	CPT0023630009	C3L-00586	Primary Tumor	20fcc809-dcdf-46c5-b40d-c1aa39c6791c	170818_UNC32-K00270_0051_BHLCCHBBXX_ACAGTG_S23_L008_R1_001.fastq.gz	e731e945-44ae-4179-9672-a2a6a1fb2d94	170818_UNC32-K00270_0051_BHLCCHBBXX_ACAGTG_S23_L008_R2_001.fastq.gz	C3L-00586	FIGO grade 1	Endometrioid carcinoma	2	6	IIIC2	under 50 %	Stage III	No	21.45	1	NA	50	0.176219029	0.004780403	0	0.006247294	0.05725825	0.110485885	0	0	0.036327449	0.023552518	0.013514406	0.007532985	0	0.047689147	0.083529995	0.018563104	0	0.64	0.001638531	0.052661005	0	0	0	0.006596366	0.104962403	0.064384568	0.649871496	0.0421249	5.66E-12	0.005944262	0.126116005	6767.884691	3748.640733	10516.52542	-0.768	-1.07	1	0	1	1	1	0	0	0	1	1	1	1	1	1	1	1	1	1	0	MSS	Mutated	Endometrioid carcinoma	normal
S022	CPT0007600003	C3L-00601	2	6	127C	C3L-00601-02	Tumor	No	C3L-00601	CPT0007600009	CPT0007600009.WholeExome.RP-1303.bam	d301c51c-52e8-4809-a1d3-8bb27f19c81e	Primary_Tumor	CPT0002900002	CPT0002900002.WholeExome.RP-1303.bam	234078e6-2b21-40f4-8aaa-2c1815f20157	Blood_Derived_Normal	CPT0007600006	C3L-00601	Primary Tumor	01b9fd20-8317-4067-84cf-e73dd8f92572	171011_UNC31-K00269_0086_AHLJLCBBXX_ACAGTG_S3_L001_R1_001.fastq.gz	5efbd40c-4225-4a7f-9920-71357ccf41f0	171011_UNC31-K00269_0086_AHLJLCBBXX_ACAGTG_S3_L001_R2_001.fastq.gz	C3L-00601	FIGO grade 1	Endometrioid carcinoma	3	3.5	IA	under 50 %	Stage I	No	25.03	0	0	57	0.079296814	0.004461257	0	0	0.029796878	0.075305468	0	0	0.026942536	0.031297567	0.02793142	0.035281171	0	0.053445267	0.083814428	0.072290433	0	0.53	0	0.009010017	0	0	0.001126745	0.005166918	0.063408919	0.022602285	0.751856594	0.038409552	1.70E-10	0.002075369	0.116480361	4850.828051	1706.11003	6556.938081	-1.63	0.0854	1	1	1	0	0	0	1	0	1	1	1	1	1	0	0	1	0	0	0	MSS	Mutated	Endometrioid carcinoma	normal
S023	CPT0063890003	C3L-00605	3	12	127N	C3L-00605-01	Tumor	No	C3L-00605	CPT0063890006	CPT0063890006.WholeExome.RP-1303.bam	ac1f750a-fa75-4c5a-96f7-4c56d795082f	Primary_Tumor	CPT0065340002	CPT0065340002.WholeExome.RP-1303.bam	4988c33a-7ed3-499b-afa3-6f8c35e176a6	Blood_Derived_Normal	CPT0063890009	C3L-00605	Primary Tumor	2ef7f6a7-6298-4cd2-a38b-9b810905ab57	170828_UNC31-K00269_0077_AHLF33BBXX_AGTTCC_S22_L006_R1_001.fastq.gz	7056adfe-ff91-4228-91b4-9954ba0148dd	170828_UNC31-K00269_0077_AHLF33BBXX_AGTTCC_S22_L006_R2_001.fastq.gz	C3L-00605	FIGO grade 2	Endometrioid carcinoma	NA	2.7	IA	under 50 %	Stage I	No	38.54	0	0	73	0.049639616	0.010183766	0	0.0226248	0.013094056	0.147629049	0.036799065	0.057276039	0.006640164	0.009964698	0.054924606	0	0	0.055385291	0.069693176	0.067875939	0	0.62	0	0	0	0.018269735	0	0.004118258	0.073710586	0.064685078	0.725635286	0.035879255	3.50E-09	0.004558948	0.091412586	4977.8832	3006.948997	7984.832197	-0.112	-0.371	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S024	CPT0026430003	C3L-00767	3	12	131	C3L-00767-01	Tumor	No	C3L-00767	CPT0026430009	CPT0026430009.WholeExome.RP-1303.bam	388eee21-fd29-4fce-995a-a5aff2058aed	Primary_Tumor	CPT0026490002	CPT0026490002.WholeExome.RP-1303.bam	cb17fbf3-1a58-4f4e-99dc-247f6b9cf870	Blood_Derived_Normal	CPT0026430006	C3L-00767	Primary Tumor	398b396a-17ba-4210-a645-a0f049b6e01e	170912_UNC31-K00269_0081_AHL3YKBBXX_CAGATC_S15_L004_R1_001.fastq.gz	b906f8b8-457b-4eed-bcc9-e9fb458b8bfa	170912_UNC31-K00269_0081_AHL3YKBBXX_CAGATC_S15_L004_R2_001.fastq.gz	C3L-00767	FIGO grade 2	Endometrioid carcinoma	4 or more	2.3	IA	under 50 %	Stage I	No	65.71	0	0	56	0.082865548	0.002742905	0.006352148	0.007693776	0.003920914	0.110666462	0.009009601	0.009198579	0.017816682	0.001468636	0.042554994	0	0	0.003981782	0	0.019412424	0	0.41	0	0	0	0.092315548	0	0.005662834	0.077628328	0.078699134	0.680938746	0.046021406	3.70E-09	0.002766177	0.10828337	3893.125442	2565.123134	6458.248576	0.486	-0.149	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S025	CPT0026530003	C3L-00769	2	5	129N	C3L-00769-01	Tumor	No	C3L-00769	CPT0026530009	CPT0026530009.WholeExome.RP-1303.bam	718e2460-1419-4f91-81bf-1f5952dc75a4	Primary_Tumor	CPT0026590002	CPT0026590002.WholeExome.RP-1303.bam	2d3390de-60ff-4dc9-8c32-5bad6614de1f	Blood_Derived_Normal	CPT0026530006	C3L-00769	Primary Tumor	b279cd43-c02c-42f0-8c35-aaf3a15d1d3d	170912_UNC31-K00269_0081_AHL3YKBBXX_ACTTGA_S14_L004_R1_001.fastq.gz	89545c45-58a9-44f7-a03e-f0c0cf2a901f	170912_UNC31-K00269_0081_AHL3YKBBXX_ACTTGA_S14_L004_R2_001.fastq.gz	C3L-00769	FIGO grade 2	Endometrioid carcinoma	2	4.5	IB	50 % or more	Stage I	No	46.64	0	0	56	0.176943387	0.002732616	0	0.010198554	0.023880414	0.139210676	0.001379743	0.015500241	0.015333559	0.017468027	0.051867091	0.007105428	0	0.011671998	0.012846689	0.060441238	0	0.64	0	0	0.020821045	0.072599294	0	0.005557191	0.100176584	0.115973086	0.616387965	0.06307061	8.81E-10	0.004079595	0.094754968	4977.305287	4634.296239	9611.601525	0.896	-0.0375	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S026	CPT0026650003	C3L-00770	3	9	127N	C3L-00770-01	Tumor	No	C3L-00770	CPT0026650009	CPT0026650009.WholeExome.RP-1303.bam	78dba76c-b8e6-448d-9176-2d289ccd5b6a	Primary_Tumor	CPT0026710002	CPT0026710002.WholeExome.RP-1303.bam	7d1c9a83-b71e-41e4-b9bf-2597f5cb7c3c	Blood_Derived_Normal	CPT0026650006	C3L-00770	Primary Tumor	866a0af4-d611-4690-89f7-a6bd28807494	170912_UNC31-K00269_0081_AHL3YKBBXX_GATCAG_S11_L003_R1_001.fastq.gz	f5bbe1ad-856b-4c71-bd70-e538c2b1898e	170912_UNC31-K00269_0081_AHL3YKBBXX_GATCAG_S11_L003_R2_001.fastq.gz	C3L-00770	FIGO grade 1	Endometrioid carcinoma	4 or more	2.7	IA	under 50 %	Stage I	Yes	45.83	0	0	73	0.124472718	0.018233193	0.04120487	0.048423841	0.011079146	0.053857024	0.008867171	0	0.062493983	0.0008	0	0	0.002332159	0.006063698	0	0.057224851	0	0.49	0	0	0.019629883	0	0.035334153	0.005909312	0.067570639	0.036781095	0.725622424	0.052156669	1.44E-08	0.003399076	0.10856077	5163.497494	2347.226471	7510.723965	-0.185	-0.0194	1	1	0	0	0	0	0	0	1	1	0	1	1	0	0	1	0	0	0	MSS	Mutated	Endometrioid carcinoma	normal
S027	CPT0026770003	C3L-00771	3	11	127N	C3L-00771-01	Tumor	No	C3L-00771	CPT0026770009	CPT0026770009.WholeExome.RP-1303.bam	5672e64e-b7e9-43fd-9929-d14b1fdc3c40	Primary_Tumor	CPT0026830002	CPT0026830002.WholeExome.RP-1303.bam	a4741ac9-5aa3-4393-9f37-17775cc03183	Blood_Derived_Normal	CPT0026770006	C3L-00771	Primary Tumor	a6fab0ab-ce4b-44cb-bf38-b9db4caa2e70	170912_UNC31-K00269_0081_AHL3YKBBXX_TAGCTT_S10_L003_R1_001.fastq.gz	8a6ab525-f78c-4814-89f3-4b487a4a847c	170912_UNC31-K00269_0081_AHL3YKBBXX_TAGCTT_S10_L003_R2_001.fastq.gz	C3L-00771	FIGO grade 2	Endometrioid carcinoma	NA	6	IIIA	50 % or more	Stage III	No	22.86	1	NA	86	0.139556902	0	0	0.002556199	0.006318375	0.105220232	0.023599304	0.027223716	0.04413059	0.022073223	0.021782958	0	0	0.031251803	0.015331903	0.051264159	0	0.64	0	0	0	0.130442357	0.019248281	0.005200559	0.267129768	0.065950716	0.500020021	0.049383477	1.99E-09	0.003655548	0.10865991	5780.984035	6048.630658	11829.61469	-1.25	-0.252	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S028	CPT0070330004	C3L-00780	2	7	129N	"C3L-00780-03,C3L-00780-05"	Tumor	No	C3L-00780	CPT0070330010	CPT0070330010.WholeExome.RP-1303.bam	14bde12d-beb9-43d7-be78-44127b3e34f8	Primary_Tumor	CPT0071010002	CPT0071010002.WholeExome.RP-1303.bam	c43591ad-8ea4-48dc-a993-19a339c73769	Blood_Derived_Normal	CPT0070330007	C3L-00780	Primary Tumor	433f4fc5-843a-4a1b-b993-dd413244a03f	170905_UNC31-K00269_0079_AHLCF7BBXX_CTTGTA_S4_L006_R1_001.fastq.gz	0ad8238f-6db6-42c0-ae96-4d7a5f0e7e7b	170905_UNC31-K00269_0079_AHLCF7BBXX_CTTGTA_S4_L006_R2_001.fastq.gz	C3L-00780	FIGO grade 2	Endometrioid carcinoma	2	1.7	IA	Not identified	Stage I	Yes	46.41	0	0	69	0.221950913	0.012153007	0	0.157403077	0.012991405	0.253723841	0.00170767	0	0.064232161	0	0.031367877	0	0	0.021648923	0.002192122	0.022225746	0	0.83	0	0	0	0.02840326	0	0.004075369	0.147513616	0.217301757	0.487682541	0.010845963	5.10E-07	0.004932524	0.12764772	6771.601901	3824.192222	10595.79412	-1.21	-1.05	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S029	CPT0070260003	C3L-00781	4	16	127N	C3L-00781-04	Tumor	No	C3L-00781	CPT0070260009	CPT0070260009.WholeExome.RP-1303.bam	3aafa910-9eeb-40ce-8373-8188414d1c9f	Primary_Tumor	CPT0071030002	CPT0071030002.WholeExome.RP-1303.bam	c0d845c2-393e-4b9e-b34a-4e3b1bb166a3	Blood_Derived_Normal	CPT0070260006	C3L-00781	Primary Tumor	0de24a9c-ebaa-45df-8405-9c753dce28b2	170830_UNC31-K00269_0078_AHLCVMBBXX_CGTACG_S9_L003_R1_001.fastq.gz	8fe73704-391c-40df-b4ed-7ddab091670b	170830_UNC31-K00269_0078_AHLCVMBBXX_CGTACG_S9_L003_R2_001.fastq.gz	C3L-00781	FIGO grade 3	Endometrioid carcinoma	4 or more	5.5	II	50 % or more	Stage II	No	32.59	1	NA	48	0.359625849	0.003669428	0	0.028471817	0.047401521	0.10620711	0.041396454	0.027796018	0.026623532	0.030621947	0.002789135	0.017896475	0	0.057724868	0.027238232	0.128965836	0	0.95	0.008152597	0.003992697	0	0	0.031426484	0.005420698	0.076433938	0.189251581	0.511971821	0.019354278	1.25E-09	0.003331587	0.194236095	6643.16418	4745.871875	11389.03605	-0.263	-0.613	0	1	1	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S030	CPT0063380003	C3L-00905	3	10	130C	C3L-00905-02	Tumor	No	C3L-00905	CPT0063380009	CPT0063380009.WholeExome.RP-1303.bam	4a895a1d-f59c-4fd0-a759-929c8581c5dc	Primary_Tumor	CPT0065250002	CPT0065250002.WholeExome.RP-1303.bam	bdecef95-6b45-4bb7-999b-c7685bce7a95	Blood_Derived_Normal	CPT0063380006	C3L-00905	Primary Tumor	f8d21c9d-a65c-4aba-9cae-71eadbe611ff	170830_UNC31-K00269_0078_AHLCVMBBXX_GCCAAT_S2_L001_R1_001.fastq.gz	b84dc177-6c03-40d2-ae16-83bb9e772349	170830_UNC31-K00269_0078_AHLCVMBBXX_GCCAAT_S2_L001_R2_001.fastq.gz	C3L-00905	FIGO grade 3	Endometrioid carcinoma	NA	4.5	IIIC1	50 % or more	Stage III	No	44.81	1	NA	64	0.053273559	0	0.009822934	0	0.0002	0.010375886	0.048482686	0	0.160223537	0.007473998	0.029367134	0	0	0.0007	0.006965088	0.011836886	0	0.35	0	0	0	0.011250673	0	0.004029459	0.0968925	0.052128545	0.671693166	0.04469791	9.64E-09	0.00140797	0.12915044	4354.875244	2073.093302	6427.968547	-0.356	-0.463	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S031	CPT0063790003	C3L-00918	2	7	131	C3L-00918-01	Tumor	No	C3L-00918	CPT0063790006	CPT0063790006.WholeExome.RP-1303.bam	789f0264-328e-4abc-bafe-07e555bb67e5	Primary_Tumor	CPT0065320002	CPT0065320002.WholeExome.RP-1303.bam	06bba088-33da-4c30-a61f-36044f8c44df	Blood_Derived_Normal	CPT0063790009	C3L-00918	Primary Tumor	3d47af04-fe23-4f4d-8ec2-66420dd82fef	170828_UNC31-K00269_0077_AHLF33BBXX_CTTGTA_S7_L008_R1_001.fastq.gz	83a66e82-d19f-4dcd-bf04-33397c2160a9	170828_UNC31-K00269_0077_AHLF33BBXX_CTTGTA_S7_L008_R2_001.fastq.gz	C3L-00918	FIGO grade 1	Endometrioid carcinoma	2	3	IA	under 50 %	Stage I	Yes	43	1	1	68	0.247713667	0.030006631	0	0.035778439	0.063111119	0.113943164	0.024126845	0.013321546	0.037066542	0.026238122	0.074014313	0	0	0.013975788	0.096956018	0.006103286	0	0.87	0.040648716	0	0	0	0.046995801	0.004322812	0.103538262	0.101417864	0.649087637	0.033989272	2.43E-08	0.004822916	0.102821213	6164.963056	4019.134039	10184.09709	-0.472	-0.752	0	0	0	0	0	0	1	0	1	1	0	1	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S032	CPT0064150004	C3L-00921	4	15	128C	"C3L-00921-02,C3L-00921-03"	Tumor	No	C3L-00921	CPT0064150007	CPT0064150007.WholeExome.RP-1303.bam	2e22b0b0-8496-4694-b710-1cd7c98b5c66	Primary_Tumor	CPT0065390002	CPT0065390002.WholeExome.RP-1303.bam	c8287e6d-4867-410b-98f2-30f66d47beea	Blood_Derived_Normal	RNAseq_C3L-00921_primary_tumor	C3L-00921	Primary Tumor	c8ac958e-2e20-4379-9568-7cc508e311de	171011_UNC31-K00269_0086_AHLJLCBBXX_CTTGTA_S7_L003_R1_001.fastq.gz	e292b646-ce77-45a1-a535-cb0dd26898e8	171011_UNC31-K00269_0086_AHLJLCBBXX_CTTGTA_S7_L003_R2_001.fastq.gz	C3L-00921	FIGO grade 2	Endometrioid carcinoma	3	4	II	50 % or more	Stage II	No	32.32	1	NA	66	0.414372638	0.030731553	0	0.013000122	0.02439787	0.229949042	0.006704016	0.015968111	0.015992922	0.015676172	0	0.0003	0	0.0001	0	0.064132247	0	0.97	0.019763217	0	0.073868667	0	0.045033677	0.006487549	0.052963288	0.065319095	0.694285073	0.039595057	1.74E-09	0.002937646	0.13841229	5550.608927	4267.943026	9818.551954	0.188	0.175	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S033	CPT0027120003	C3L-00932	2	8	128C	C3L-00932-01	Tumor	No	C3L-00932	CPT0027120009	CPT0027120009.WholeExome.RP-1303.bam	3fb1df82-1f6e-4e56-84c2-3b56d905ac84	Primary_Tumor	CPT0027180002	CPT0027180002.WholeExome.RP-1303.bam	22a61fbf-a8af-4360-8ddd-2146432a5ac5	Blood_Derived_Normal	CPT0027120006	C3L-00932	Primary Tumor	dd5354a9-7c2a-48a3-8381-96ed8ee9ea08	170912_UNC31-K00269_0081_AHL3YKBBXX_CTTGTA_S13_L004_R1_001.fastq.gz	14fc8a67-8464-475b-9c69-0ab40757f0d7	170912_UNC31-K00269_0081_AHL3YKBBXX_CTTGTA_S13_L004_R2_001.fastq.gz	C3L-00932	FIGO grade 2	Endometrioid carcinoma	3	1	IA	Not identified	Stage I	No	47.82	0	0	67	0.095558177	0	0.0004	0	0.016122823	0.120844083	0.003705692	0.005956481	0	0	0.02872328	0	0	0.003502029	0.029154427	0.082780907	0	0.47	0.006576348	0	0	0.076648017	0	0.004444401	0.117913805	0.141805626	0.602867088	0.04509666	5.28E-09	0.001916371	0.085956044	4402.548423	4455.576971	8858.125394	1.23	0.41	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S034	CPT0016260003	C3L-00938	4	15	129C	C3L-00938-01	Tumor	No	C3L-00938	CPT0016260006	CPT0016260006.WholeExome.RP-1303.bam	332a85b8-bd0a-4610-9bc3-c19e9e7c7924	Primary_Tumor	CPT0016330002	CPT0016330002.WholeExome.RP-1303.bam	f39b8a04-7400-4564-a764-0ea82dc9495b	Blood_Derived_Normal	CPT0016260009	C3L-00938	Primary Tumor	893adafa-41f8-4469-9c19-4b3c91b82e20	170818_UNC32-K00270_0051_BHLCCHBBXX_CCGTCC_S3_L001_R1_001.fastq.gz	aafe7ff3-0502-4175-a4a9-887ae8c2ec5b	170818_UNC32-K00270_0051_BHLCCHBBXX_CCGTCC_S3_L001_R2_001.fastq.gz	C3L-00938	FIGO grade 2	Endometrioid carcinoma	1	5.5	IB	50 % or more	Stage I	No	45.53	1	NA	53	0.116555551	0.042521713	0	0	0.075508375	0.140170374	0	0.030691074	0	0.00842545	0.027592607	0	0	0.017126022	0.012975359	0.067062409	0	0.64	0	0.020200039	0	0.081171027	0	0.006872997	0.184967556	0.335080023	0.290393925	0.051605789	3.65E-09	0.007488289	0.123591418	8516.249705	8257.35682	16773.60652	0.486	-0.34	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	low
S035	CPT0016830003	C3L-00942	1	3	130C	C3L-00942-01	Tumor	No	C3L-00942	CPT0016830006	CPT0016830006.WholeExome.RP-1303.bam	e4a34a68-cdb6-40b9-ac1b-a1328f72b67d	Primary_Tumor	CPT0016970001	CPT0016970001.WholeExome.RP-1303.bam	60bb0611-e14f-4042-b148-492cff530e9c	Blood_Derived_Normal	CPT0016830009	C3L-00942	Primary Tumor	34b5b547-c104-4c3b-b809-8c5fc7bf841d	170818_UNC32-K00270_0051_BHLCCHBBXX_TTAGGC_S14_L008_R1_001.fastq.gz	54fe3f69-db4c-4bb1-bfe6-957aab9aaf4b	170818_UNC32-K00270_0051_BHLCCHBBXX_TTAGGC_S14_L008_R2_001.fastq.gz	C3L-00942	FIGO grade 1	Endometrioid carcinoma	None	4.5	IA	under 50 %	Stage I	No	31.58	0	0	64	0.20566446	0.012869295	0.010235752	0	0.041096529	0.124492647	0.002002463	0.030148189	0.095737426	0.0004	0.04054915	0	0.002365816	0	0.047263698	0.123466351	0	0.8	0.012958822	0	0	0.05073331	0	0.005177041	0.080990031	0.12990102	0.61476397	0.033872945	4.10E-08	0.003407333	0.131887618	6057.850781	3909.219425	9967.070206	0.516	0.294	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S036	CPT0027520003	C3L-00946	1	4	130N	C3L-00946-01	Tumor	No	C3L-00946	CPT0027520009	CPT0027520009.WholeExome.RP-1303.bam	e3c6f555-f860-4a9f-a8b1-7f4bc0b2c2a4	Primary_Tumor	CPT0027580002	CPT0027580002.WholeExome.RP-1303.bam	2df9b35b-bbe9-435b-97be-1bb9695d3946	Blood_Derived_Normal	CPT0027520006	C3L-00946	Primary Tumor	dd5912cb-695c-487b-9267-291f8ebb54bb	171011_UNC31-K00269_0086_AHLJLCBBXX_ATCACG_S2_L001_R1_001.fastq.gz	39a421b8-2826-44af-8ee6-af72e9a27cfa	171011_UNC31-K00269_0086_AHLJLCBBXX_ATCACG_S2_L001_R2_001.fastq.gz	C3L-00946	FIGO grade 1	Endometrioid carcinoma	1	3.9	IB	50 % or more	Stage I	No	17.64	1	1	64	0.167282206	0.00363144	0	0.239323207	0.040816315	0.174904075	0.014442484	0	0.051160224	0	0.105500717	0	0	0.00172655	0.045841298	0.049229317	0	0.95	0	0	0	0	0.056142168	0.004359049	0.094765293	0.102365644	0.668268543	0.032133044	8.38E-09	0.003602011	0.094506407	5643.777667	4238.332575	9882.110241	-0.73	-0.712	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S037	CPT0027420003	C3L-00947	1	1	129N	C3L-00947-01	Tumor	No	C3L-00947	CPT0027420009	CPT0027420009.WholeExome.RP-1303.bam	c20cc1ed-0cee-4d29-b4f7-bd705b2faa78	Primary_Tumor	CPT0027480002	CPT0027480002.WholeExome.RP-1303.bam	c707d921-31f0-4460-8dcd-f000420b0b8c	Blood_Derived_Normal	CPT0027420006	C3L-00947	Primary Tumor	989082f5-abb2-4d47-a6b3-e3560b9b38d3	171011_UNC31-K00269_0086_AHLJLCBBXX_ATTCCT_S5_L002_R1_001.fastq.gz	8d9b3ee8-b37d-4e67-856c-149dcd51f602	171011_UNC31-K00269_0086_AHLJLCBBXX_ATTCCT_S5_L002_R2_001.fastq.gz	C3L-00947	FIGO grade 2	Endometrioid carcinoma	2	1.8	IA	Not identified	Stage I	Yes	36.84	0	0	71	0.15312548	0.005772881	0	0.004399126	0.032144626	0.208800355	0.005438661	0.054421936	0	0.029244357	0.050743363	0	0	0.089815096	0.070066347	0.089063113	0	0.87	0.017523387	0.0128425	0	0.046598774	0	0.004528554	0.13572922	0.039355715	0.685612359	0.044274755	1.35E-08	0.004577919	0.085921464	5752.438575	2629.892485	8382.33106	-0.364	-0.652	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S038	CPT0016370003	C3L-00949	1	2	130C	C3L-00949-01	Tumor	No	C3L-00949	CPT0016370006	CPT0016370006.WholeExome.RP-1303.bam	a748c37a-854b-404b-a0cc-57ca932c74c3	Primary_Tumor	CPT0016440002	CPT0016440002.WholeExome.RP-1303.bam	7d65bd6b-fd23-4d09-8555-9dcd266dc171	Blood_Derived_Normal	CPT0016370009	C3L-00949	Primary Tumor	acc81064-08f0-457b-9629-1bb742e4ceb6	170823_UNC31-K00269_0075_AHLCW5BBXX_CAGATC_S5_L008_R1_001.fastq.gz	1e750be5-488d-4a05-9c08-928700638328	170823_UNC31-K00269_0075_AHLCW5BBXX_CAGATC_S5_L008_R2_001.fastq.gz	C3L-00949	FIGO grade 1	Endometrioid carcinoma	2	2.5	IA	under 50 %	Stage I	Yes	37.69	1	1	64	0.172918892	0.01803949	0.00687843	0	0.004253386	0.130015737	0.006207267	0.010850501	0.00770542	0.014017651	0.00110555	0	0	0.006541175	0	0.065985323	0	0.49	0	0	0.016716326	0.028764852	0	0.005098513	0.091623186	0.118553064	0.616466321	0.047321103	2.73E-09	0.002330233	0.118607577	4851.094335	4333.499845	9184.59418	0.544	0.371	0	0	0	1	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S039	CPT0027320003	C3L-00961	2	8	131	C3L-00961-01	Tumor	No	C3L-00961	CPT0027320009	CPT0027320009.WholeExome.RP-1303.bam	f6887135-5cc9-4373-92d0-658826ad5f5e	Primary_Tumor	CPT0027380002	CPT0027380002.WholeExome.RP-1303.bam	5cb5ae6c-4a2d-471f-8f28-11c1622d7d2a	Blood_Derived_Normal	CPT0027320006	C3L-00961	Primary Tumor	339ad507-4d3e-4c9e-ae1c-5a207645cf9b	171011_UNC31-K00269_0086_AHLJLCBBXX_ACTGAT_S4_L002_R1_001.fastq.gz	6af2d835-4e67-4d59-9cf9-da8f0d197f44	171011_UNC31-K00269_0086_AHLJLCBBXX_ACTGAT_S4_L002_R2_001.fastq.gz	C3L-00961	FIGO grade 1	Endometrioid carcinoma	2	4.5	IA	under 50 %	Stage I	No	28.5	0	0	59	0.36866113	0.014219009	0	0.074511355	0.064399209	0.179213063	0.060779007	0	0.083275431	0.010868604	0.03239514	0	0	0.007948338	0.073904574	0.109885559	0	1.14	0.02579255	0	0	0.034147031	0	0.004460847	0.080876696	0.138551785	0.623422151	0.040021967	2.78E-09	0.003183905	0.109482646	5768.565065	5102.751057	10871.31612	0.474	-0.0502	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S040	CPT0016490003	C3L-00963	2	8	129C	C3L-00963-01	Tumor	No	C3L-00963	CPT0016490006	CPT0016490006.WholeExome.RP-1303.bam	317010d0-d173-46e5-92db-8b5c77f6e444	Primary_Tumor	CPT0016580002	CPT0016580002.WholeExome.RP-1303.bam	3b1346b2-15c4-426d-9a84-80205c0cedb4	Blood_Derived_Normal	CPT0016490009	C3L-00963	Primary Tumor	1041d695-f7af-49a9-a30c-b81115bd4ea7	170823_UNC31-K00269_0075_AHLCW5BBXX_CTTGTA_S2_L007_R1_001.fastq.gz	dfa1ae1e-a25a-483a-8e30-29a16c5d9939	170823_UNC31-K00269_0075_AHLCW5BBXX_CTTGTA_S2_L007_R2_001.fastq.gz	C3L-00963	NA	NA	1	2.6	IB	50 % or more	Stage I	Yes	34.89	1	NA	59	0.190698911	0.005672928	0	0.045830018	0.050662903	0.152417514	0.07376121	0.002564539	0	0	0.10639045	0	0.007246349	0	0.044134912	0.078174173	0	0.81	0	0	0	0.052446093	0	0.005209019	0.115537488	0.06407184	0.674945653	0.035251651	1.18E-09	0.003356582	0.101627765	6255.195762	3781.400158	10036.59592	-1.39	-1.19	1	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	MSS	WT	NA	normal
S041	CPT0080980003	C3L-01246	2	7	127N	C3L-01246-01	Tumor	No	C3L-01246	CPT0080980009	CPT0080980009.WholeExome.RP-1303.bam	266bc8ac-06f0-4e08-a183-b089bc18a036	Primary_Tumor	CPT0081030002	CPT0081030002.WholeExome.RP-1303.bam	2b17f82f-6232-45c1-8403-dfb743b7c345	Blood_Derived_Normal	CPT0080980006	C3L-01246	Primary Tumor	150efab8-0b73-4f1e-be49-e317b0d739ee	170906_UNC32-K00270_0058_BHLJ7FBBXX_CTTGTA_S20_L005_R1_001.fastq.gz	f5b7c2a1-9ed4-451e-880b-9ad37fda8ddb	170906_UNC32-K00270_0058_BHLJ7FBBXX_CTTGTA_S20_L005_R2_001.fastq.gz	C3L-01246	NA	NA	1	2.3	IA	under 50 %	Stage I	No	39.14	0	NA	62	0.079155671	0.017781494	0	0	0.060980028	0.0947925	0	0.041579984	0.008591921	0.03118917	0.024890194	0	0	0	0.023992102	0.015260895	0	0.45	0	0	0	0.05178604	0	0.002196903	0.114757023	0.171428644	0.614457941	0.031593671	8.60E-09	0.003184432	0.062381378	4979.833929	5711.460988	10691.29492	-0.808	-1.33	0	1	0	0	0	1	0	0	0	1	0	0	0	0	1	1	0	0	0	MSS	WT	NA	normal
S042	CPT0080700003	C3L-01247	3	10	128N	C3L-01247-01	Tumor	No	C3L-01247	CPT0080700009	CPT0080700009.WholeExome.RP-1303.bam	8dea3157-8e37-4333-b9cc-6ced8fc244ec	Primary_Tumor	CPT0080800002	CPT0080800002.WholeExome.RP-1303.bam	042952fd-d733-4298-bd7e-804f68a03328	Blood_Derived_Normal	CPT0080700006	C3L-01247	Primary Tumor	20f8e780-92e0-43e6-b7a4-6e84f39235c8	170906_UNC32-K00270_0058_BHLJ7FBBXX_TAGCTT_S18_L005_R1_001.fastq.gz	340e18d4-ab3f-4a19-8efa-19a46955ea2f	170906_UNC32-K00270_0058_BHLJ7FBBXX_TAGCTT_S18_L005_R2_001.fastq.gz	C3L-01247	NA	Serous carcinoma	1	11	IIIC1	50 % or more	Stage III	No	38.44	1	NA	63	0.145117849	0.043941888	0	0	0.04266191	0.126920318	0	0.027718393	0	0.020459611	0.046517276	0	0	0	0.02712678	0.038044018	0	0.65	0.005624186	0.032517355	0	0.093350416	0	0.003136131	0.255350012	0.270098168	0.324793568	0.057038104	1.53E-09	0.003692105	0.085891909	6499.908029	6791.999903	13291.90793	0.627	0.109	0	0	0	0	0	1	0	0	0	1	0	1	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	low
S043	CPT0080300003	C3L-01248	1	1	130C	C3L-01248-01	Tumor	No	C3L-01248	CPT0080300006	CPT0080300006.WholeExome.RP-1303.bam	9da0f4ae-f3e7-4e37-b1fc-b16f7b0600d7	Primary_Tumor	CPT0080340001	CPT0080340001.WholeExome.RP-1303.bam	6c3c775a-35d5-4418-84c1-9e6421287e19	Blood_Derived_Normal	CPT0080300009	C3L-01248	Primary Tumor	f19a6801-b116-4e0d-b755-5f72f604f648	170908_UNC31-K00269_0080_BHLJ52BBXX_CCGTCC_S24_L006_R1_001.fastq.gz	848dfac4-6067-4a87-8e2c-887b5e4a3272	170908_UNC31-K00269_0080_BHLJ52BBXX_CCGTCC_S24_L006_R2_001.fastq.gz	C3L-01248	FIGO grade 1	Endometrioid carcinoma	1	6.3	IB	50 % or more	Stage II	No	59.78	0	0	42	0.124923504	0.004972786	0	0.105643912	0.016167916	0.123462338	0	0	0	0.014830874	0.054248224	0	0	0.046343582	0.061050076	0	0	0.65	0.00128331	0	0	0.097073479	0	0.004866398	0.133829893	0.396427238	0.348610921	0.041579539	4.37E-08	0.003523899	0.07116207	6239.261385	6134.476114	12373.7375	-0.0888	-1.32	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S044	CPT0080880003	C3L-01249	1	2	128C	C3L-01249-01	Tumor	No	C3L-01249	CPT0080880009	CPT0080880009.WholeExome.RP-1303.bam	c5e6c695-c1ff-48bf-af3d-18e2d48347c3	Primary_Tumor	CPT0080920002	CPT0080920002.WholeExome.RP-1303.bam	33dbc85d-be68-4786-9ad8-967e528491d3	Blood_Derived_Normal	CPT0080880006	C3L-01249	Primary Tumor	5bdc0383-216a-479a-b641-502eed2b241a	170906_UNC32-K00270_0058_BHLJ7FBBXX_GGCTAC_S17_L005_R1_001.fastq.gz	1e55bad8-2e97-4693-9859-81d5834c997f	170906_UNC32-K00270_0058_BHLJ7FBBXX_GGCTAC_S17_L005_R2_001.fastq.gz	C3L-01249	FIGO grade 2	Endometrioid carcinoma	1	6.5	IA	under 50 %	Stage I	No	38.89	0	0	65	0.186223789	0.02868622	0	0.266741893	0.018306136	0.213574815	0.02101373	0	0.106226948	0	0.00418142	0	0	0.058490698	0.034617457	0.047550012	0	1.02	0	0	0.019629646	0	0.014757236	0.005506597	0.133562549	0.082586753	0.615682507	0.022851227	5.71E-09	0.011554706	0.128255657	7668.0101	4435.707788	12103.71789	-1.66	-0.98	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S045	CPT0080610003	C3L-01252	1	1	128C	C3L-01252-01	Tumor	No	C3L-01252	CPT0080610009	CPT0080610009.WholeExome.RP-1303.bam	408d28c0-f5ef-4f57-8f2b-58203af65413	Primary_Tumor	CPT0080660002	CPT0080660002.WholeExome.RP-1303.bam	107f1193-5129-4ebc-a826-cb3619de39b7	Blood_Derived_Normal	CPT0080610006	C3L-01252	Primary Tumor	d36d42d2-afb4-4098-bac2-2c0d503c2f67	170906_UNC32-K00270_0058_BHLJ7FBBXX_GATCAG_S19_L005_R1_001.fastq.gz	992384ee-8c0e-4c30-8732-561df93e281a	170906_UNC32-K00270_0058_BHLJ7FBBXX_GATCAG_S19_L005_R2_001.fastq.gz	C3L-01252	FIGO grade 1	Endometrioid carcinoma	4 or more	0.9	IA	under 50 %	Stage I	Yes	38.41	0	0	76	0.222912019	0	0	0.027284937	0.015098039	0.248352302	0.055190295	0.02840839	0	0.010769803	0.033949534	0	0.001	0	0.01494661	0.036872541	0	0.77	0	0.040490228	0	0.032160254	0.002601277	0.006402477	0.12208323	0.137741651	0.531240397	0.038989869	2.99E-09	0.005223646	0.158318728	6434.325792	4965.604393	11399.93018	-0.0836	0.946	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	0	1	MSI-H	WT	Endometrioid carcinoma	normal
S046	CPT0080400003	C3L-01253	3	10	131	C3L-01253-01	Tumor	No	C3L-01253	CPT0080400009	CPT0080400009.WholeExome.RP-1303.bam	bfc5eee1-fa36-4b16-990a-a7ab210b093f	Primary_Tumor	CPT0080440002	CPT0080440002.WholeExome.RP-1303.bam	1f4b8c6c-efac-49b0-a09c-7c8eced9bc5e	Blood_Derived_Normal	CPT0080400006	C3L-01253	Primary Tumor	947060cd-6c80-47b7-8330-3b0d802d9d50	170906_UNC32-K00270_0058_BHLJ7FBBXX_ACTTGA_S24_L006_R1_001.fastq.gz	430e7fee-c564-4b6d-9c18-3249e79c57d1	170906_UNC32-K00270_0058_BHLJ7FBBXX_ACTTGA_S24_L006_R2_001.fastq.gz	C3L-01253	FIGO grade 2	Endometrioid carcinoma	2	5	IB	50 % or more	Stage I	Yes	31.83	1	1	77	0.033678849	0	0	0	0.006033839	0.112393435	0.006194443	0.011483769	0	0.0005	0.015883132	0	0	0.005305717	0.006521843	0.097284872	0	0.36	0	0	0	0.064674674	0	0.006663685	0.249481246	0.083032527	0.491777716	0.06542584	1.15E-08	0.00262345	0.100995526	5528.531387	6515.371607	12043.90299	0.26	0.782	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	low
S047	CPT0073450003	C3L-01256	1	3	129C	C3L-01256-01	Tumor	No	C3L-01256	CPT0073450009	CPT0073450009.WholeExome.RP-1303.bam	2dd3138f-f66e-431c-8401-bbc8ced59226	Primary_Tumor	CPT0073470002	CPT0073470002.WholeExome.RP-1303.bam	1044b951-8e3a-4772-a4ed-a38c6715f4df	Blood_Derived_Normal	CPT0073450006	C3L-01256	Primary Tumor	aafd76a4-f0d2-4e99-bc97-34a7f2c06846	170905_UNC31-K00269_0079_AHLCF7BBXX_ATGTCA_S23_L007_R1_001.fastq.gz	9c0ad385-aa72-4df1-a53b-57f77602a7d7	170905_UNC31-K00269_0079_AHLCF7BBXX_ATGTCA_S23_L007_R2_001.fastq.gz	C3L-01256	FIGO grade 1	Endometrioid carcinoma	4 or more	4.3	IB	50 % or more	Stage I	Yes	34.37	0	0	75	0.192326822	0.059757333	0	0.042566719	0.00987097	0.165327623	0.006758145	0.051242322	0	0.015292295	0.029434116	0	0	0.041585333	0	0.108651861	0	0.78	0	0	0	0.051687953	0.005498505	0.006931651	0.091572847	0.10085879	0.633061315	0.045018409	4.85E-09	0.005441517	0.117115467	6298.298259	5548.489367	11846.78763	0.245	-0.0432	0	0	0	1	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S048	CPT0073520003	C3L-01257	2	7	128N	C3L-01257-01	Tumor	No	C3L-01257	CPT0073520009	CPT0073520009.WholeExome.RP-1303.bam	ef0001d3-0686-4ba7-9c1d-fbeac4338b84	Primary_Tumor	CPT0073580002	CPT0073580002.WholeExome.RP-1303.bam	a034b8b1-e2f4-40c3-b003-b6cde631088e	Blood_Derived_Normal	CPT0073520013	C3L-01257	Primary Tumor	7c9d4661-f204-4d60-b0da-9de70a2d29b7	170906_UNC32-K00270_0058_BHLJ7FBBXX_AGTTCC_S14_L004_R1_001.fastq.gz	b802ec84-9a75-4c16-bf86-e3b4e2e29561	170906_UNC32-K00270_0058_BHLJ7FBBXX_AGTTCC_S14_L004_R2_001.fastq.gz	C3L-01257	FIGO grade 1	Endometrioid carcinoma	2	8	IA	under 50 %	Stage I	No	17.11	0	0	71	0.155098137	0.006471643	0.00442106	0	0.070700628	0.279895555	0	0	0.145158987	0.0006	0.027640251	0.062742251	0.014150682	0	0.081580939	0.109470307	0	0.98	0	0.022112668	0	0	0	0.007955392	0.063623215	0.030422016	0.71857344	0.035453503	2.80E-09	0.007146413	0.136826018	7805.287716	3346.731612	11152.01933	0.585	-0.287	0	1	0	0	0	0	0	0	1	1	0	0	1	0	1	1	1	1	0	MSI-H	WT	Endometrioid carcinoma	normal
S049	CPT0073730003	C3L-01275	3	9	129C	C3L-01275-01	Tumor	No	C3L-01275	CPT0073730009	CPT0073730009.WholeExome.RP-1303.bam	1ebdcb02-870f-49bb-bf92-81e1c1d0099b	Primary_Tumor	CPT0073760002	CPT0073760002.WholeExome.RP-1303.bam	ab514c97-e709-4ebc-8e68-728782297243	Blood_Derived_Normal	CPT0073730006	C3L-01275	Primary Tumor	4b44bd70-9e38-452a-878f-4875577eaa2c	170905_UNC31-K00269_0079_AHLCF7BBXX_GGCTAC_S1_L006_R1_001.fastq.gz	555f14f3-dae8-486d-8306-df6603731765	170905_UNC31-K00269_0079_AHLCF7BBXX_GGCTAC_S1_L006_R2_001.fastq.gz	C3L-01275	FIGO grade 2	Endometrioid carcinoma	NA	5	IB	50 % or more	Stage I	No	32.06	1	1	65	0.117139625	0.016770321	0	0.042736941	0.019701249	0.18378076	0.008110889	0	0.11382124	0.019563355	0.02729506	0	0	0.050302654	0.033005898	0.029312715	0	0.83	0.015382924	0.023439594	0	0	0.129636775	0.005730778	0.148295618	0.109255916	0.585365506	0.027176374	2.25E-09	0.005005061	0.119170745	6267.438479	5035.794842	11303.23332	-0.594	-0.245	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	1	1	0	MSI-H	WT	Endometrioid carcinoma	normal
S050	CPT0077650003	C3L-01282	1	4	128C	C3L-01282-01	Tumor	No	C3L-01282	CPT0077650006	CPT0077650006.WholeExome.RP-1303.bam	0deb5f00-8493-433d-a994-78fb8b5ad7b3	Primary_Tumor	CPT0080070001	CPT0080070001.WholeExome.RP-1303.bam	c9435953-c43f-4d11-9d66-af1c5b100aaf	Blood_Derived_Normal	CPT0077650009	C3L-01282	Primary Tumor	1055a2ed-0ffd-4a47-b98d-31f79271fecc	170908_UNC31-K00269_0080_BHLJ52BBXX_AGTCAA_S23_L006_R1_001.fastq.gz	0d5983fb-0657-4a02-8a14-3606ea81b0d8	170908_UNC31-K00269_0080_BHLJ52BBXX_AGTCAA_S23_L006_R2_001.fastq.gz	C3L-01282	FIGO grade 3	Endometrioid carcinoma	NA	3	IA	under 50 %	Stage I	No	31.96	1	NA	64	0.151125497	0	0.00906967	0	0.070048837	0.168158407	0.002996522	0.023889679	0.027204716	0.008889822	0.05385969	0	0	0	0.073799185	0.145274304	0	0.83	0.016382998	0	0	0.079300673	0	0.006071288	0.095754957	0.051567513	0.69082846	0.03522931	1.60E-09	0.004295623	0.116252847	5760.986958	3702.652027	9463.638986	-0.524	-0.17	0	1	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S051	CPT0064210003	C3L-01304	1	4	129C	C3L-01304-01	Tumor	No	C3L-01304	CPT0064210006	CPT0064210006.WholeExome.RP-1303.bam	16007f80-3a3a-47cd-95c6-eb725c6db78c	Primary_Tumor	CPT0065400002	CPT0065400002.WholeExome.RP-1303.bam	b490469f-6983-4d55-b6f8-b884587b3bfc	Blood_Derived_Normal	CPT0064210009	C3L-01304	Primary Tumor	2c0d1a81-0278-4dcf-99b1-8b846369e7a2	170828_UNC31-K00269_0077_AHLF33BBXX_GTGGCC_S21_L006_R1_001.fastq.gz	06f5c317-1033-4c7a-b439-095b129762d6	170828_UNC31-K00269_0077_AHLF33BBXX_GTGGCC_S21_L006_R2_001.fastq.gz	C3L-01304	FIGO grade 1	Endometrioid carcinoma	3	3.7	IA	under 50 %	Stage I	Yes	41.44	0	0	68	0.145822992	0	0	0	0.077019546	0.202442392	0	0	0.02503175	0	0	0.025389225	0	0.039919707	0.021802422	0.093416052	0	0.74	0	0.037699444	0.0003	0.071131317	0	0.00208603	0.109129131	0.045042235	0.567631369	0.169993489	4.92E-10	0.00481661	0.101301135	6691.117149	3554.390593	10245.50774	0.158	-0.489	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S052	CPT0064290004	C3L-01307	1	4	127C	"C3L-01307-01,C3L-01307-03"	Tumor	No	C3L-01307	CPT0064290007	CPT0064290007.WholeExome.RP-1303.bam	a183c0c4-67d7-4c30-9c5e-3d7bbf8e8e02	Primary_Tumor	CPT0065410002	CPT0065410002.WholeExome.RP-1303.bam	347e1925-154e-4498-9fd8-9761a9429e33	Blood_Derived_Normal	CPT0064290010	C3L-01307	Primary Tumor	7eae300f-fe7f-4059-876c-659d575a8f34	170828_UNC31-K00269_0077_AHLF33BBXX_GTTTCG_S23_L006_R1_001.fastq.gz	9ad113e3-3bed-4906-a9d0-adc6e81379b4	170828_UNC31-K00269_0077_AHLF33BBXX_GTTTCG_S23_L006_R2_001.fastq.gz	C3L-01307	FIGO grade 3	Endometrioid carcinoma	3	3.5	IVB	under 50 %	Stage IV	Yes	31.63	1	NA	74	0.143980157	0	0.021983045	0.009127693	0.016577828	0.154202848	0.003833063	0	0.141429525	0	0.037878075	0	0.028690669	0.055970953	0.021676235	0.057892742	0	0.72	0	0	0	0.026757166	0	0.012745927	0.131387928	0.069778323	0.531150815	0.06036526	3.73E-09	0.003685652	0.190886091	5924.849456	3821.608966	9746.458422	-0.915	-0.458	0	1	0	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S053	CPT0077770003	C3L-01311	1	3	128N	C3L-01311-01	Tumor	No	C3L-01311	CPT0077770013	CPT0077770013.WholeExome.RP-1303.bam	11cc9aab-415f-42be-9fd2-f9e4d9b0e21c	Primary_Tumor	CPT0080090002	CPT0080090002.WholeExome.RP-1303.bam	cf8616a6-22c6-4235-80b4-9e85d9f6ad40	Blood_Derived_Normal	CPT0077770006	C3L-01311	Primary Tumor	391b8dfd-1857-41ff-8af2-ea0830668f60	170905_UNC31-K00269_0079_AHLCF7BBXX_ATTCCT_S12_L003_R1_001.fastq.gz	5b4f8676-cead-4e7a-b932-58fb3d37f3a1	170905_UNC31-K00269_0079_AHLCF7BBXX_ATTCCT_S12_L003_R2_001.fastq.gz	C3L-01311	FIGO grade 1	Endometrioid carcinoma	None	3	IA	Not identified	Stage I	No	37.11	0	0	55	0.077021852	0.003387154	0	0	0.076748995	0.104517526	0	0	0.031163318	0.005798878	0.054539991	0.032685341	0	0.022069207	0.079008992	0.109550741	0	0.65	0.0009	0.044567053	0	0	0.008075333	0.004215926	0.143556921	0.109470974	0.574575636	0.06007514	4.74E-09	0.006587758	0.101517641	6666.469204	4282.074991	10948.54419	-0.0232	-0.851	0	1	0	1	0	0	0	0	1	1	0	1	0	1	0	1	1	0	1	MSS	Mutated	Endometrioid carcinoma	normal
S054	CPT0063670003	C3L-01312	2	5	130C	C3L-01312-01	Tumor	No	C3L-01312	CPT0063670006	CPT0063670006.WholeExome.RP-1303.bam	3761c9f6-ed8b-461c-b3a9-4d657d4a503c	Primary_Tumor	CPT0065300002	CPT0065300002.WholeExome.RP-1303.bam	f4e766bd-7f64-420a-9972-da5865c8deb0	Blood_Derived_Normal	CPT0063670009	C3L-01312	Primary Tumor	bcbd006a-fd60-43db-905d-aa6e729f314a	170828_UNC31-K00269_0077_AHLF33BBXX_TAGCTT_S6_L008_R1_001.fastq.gz	f3db77a2-db19-4942-8c2e-3b69f81a956b	170828_UNC31-K00269_0077_AHLF33BBXX_TAGCTT_S6_L008_R2_001.fastq.gz	C3L-01312	FIGO grade 1	Endometrioid carcinoma	1	4	IA	under 50 %	Stage I	No	31.96	0	0	56	0.22358277	0.007996144	0.009819622	0.030273428	0.024328606	0.208602464	0.003921947	0.015489192	0	0.016955087	0.079006224	0	0	0.024427266	0.010177208	0.092732909	0	0.77	0	0	0	0.017436486	0.005250649	0.005863154	0.103001166	0.146545755	0.579011207	0.045626743	1.02E-09	0.005458865	0.114493109	6385.554716	4262.424062	10647.97878	-0.0142	-0.109	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S055	CPT0093280003	C3L-01744	1	3	127N	C3L-01744-01	Tumor	No	C3L-01744	CPT0093280009	CPT0093280009.WholeExome.RP-1303.bam	a977336f-32d5-4311-bfc0-16c88e46776a	Primary_Tumor	CPT0093320002	CPT0093320002.WholeExome.RP-1303.bam	df7c3154-2716-4dde-90aa-3424cabac508	Blood_Derived_Normal	CPT0093280006	C3L-01744	Primary Tumor	0eefe67a-b297-4c2f-87ad-d25b83e43a2b	171205_UNC32-K00270_0069_BHN2HGBBXX_ACTGAT_S22_L006_R1_001.fastq.gz	6d97b258-2fc8-4b10-9c6c-d1e7dac46106	171205_UNC32-K00270_0069_BHN2HGBBXX_ACTGAT_S22_L006_R2_001.fastq.gz	C3L-01744	NA	NA	2	2.2	IA	under 50 %	Stage I	No	46.45	0	NA	62	0.060144906	0.0007	0.015350342	0	0.029584537	0.137049713	0.007310619	0.02761867	0	0.00669145	0.002045284	0	0	0.01279678	0.084212413	0.162358545	0	0.61	0.011223627	0	0.02209679	0	0.030856792	0.007891409	0.054719455	0.030381439	0.728614796	0.044015107	7.56E-11	0.003346583	0.131031212	5590.277688	1682.151896	7272.429584	-1.8	-1.12	0	1	0	1	0	0	0	0	1	1	0	0	1	1	0	1	1	1	0	MSI-H	WT	NA	normal
S056	CPT0113690003	C3L-01925	4	15	127N	C3L-01925-07	Tumor	No	C3L-01925	CPT0113690009	CPT0113690009.WholeExome.RP-1303.bam	3d47985c-6c06-4b8b-ba91-cbe7815892a8	Primary_Tumor	CPT0114410002	CPT0114410002.WholeExome.RP-1303.bam	38c5bbb9-3142-418c-ad0c-d74c8f2e217a	Blood_Derived_Normal	RNAseq_C3L-01925_primary_tumor	C3L-01925	Primary Tumor	49190371-ec2a-420f-a804-0931a346d206	180508_UNC31-K00269_0128_BHTY7KBBXX_AGTCAA_S23_L006_R1_001.fastq.gz	c8dfbe14-a49c-4838-95c7-c9b9ed81633a	180508_UNC31-K00269_0128_BHTY7KBBXX_AGTCAA_S23_L006_R2_001.fastq.gz	NA	NA	Serous carcinoma	None	4.5	IVB	50 % or more	Stage IV	No	27.66	1	NA	65	0.115811487	0	0	0	0.018902943	0.090333965	0.009959128	0.003605974	0.043674035	0.030012721	0.036534493	0	0	0.011458756	0.045137299	0.008603041	0	0.42	0	0	0	0.00596616	0	0.003108123	0.100179506	0.245624092	0.583292424	0.013339386	1.86E-09	0.001663694	0.052792773	3163.142174	4255.959916	7419.10209	-2.37	-1.45	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S057	CPT0066620003	C3N-00151	4	16	129N	C3N-00151-03	Tumor	No	C3N-00151	CPT0066620006	CPT0066620006.WholeExome.RP-1303.bam	719ccc63-3efb-4627-99f8-b227ad0c9a0d	Primary_Tumor	CPT0071660002	CPT0071660002.WholeExome.RP-1303.bam	9b86c86a-b2db-4215-b4d3-b244b3ec6784	Blood_Derived_Normal	CPT0066620009	C3N-00151	Primary Tumor	325918b9-3905-49ff-b4f6-f76a88e30301	170830_UNC31-K00269_0078_AHLCVMBBXX_TTAGGC_S8_L008_R1_001.fastq.gz	31961972-9d79-45d4-a53c-b80875dd8e9a	170830_UNC31-K00269_0078_AHLCVMBBXX_TTAGGC_S8_L008_R2_001.fastq.gz	C3N-00151	FIGO grade 2	Endometrioid carcinoma	2	NA	IB	50 % or more	Stage I	Unknown	27.1	0	0	60	0.178005848	0	0	0.031272954	0.079014882	0.08291912	0.005009947	0	0.059535132	0.124378981	0	0.016912327	0	0.041497227	0.096795497	0.086170937	0	0.84	0	0	0	0.018592465	0.019894683	0.016229609	0.110029945	0.066982605	0.648503347	0.037353248	8.19E-09	0.003059245	0.117841991	6137.36728	3508.374749	9645.742029	-1.45	-0.453	1	0	1	0	1	0	0	1	1	1	1	0	1	0	0	1	1	1	1	MSS	Mutated	Endometrioid carcinoma	normal
S058	CPT0017870003	C3N-00200	3	9	128N	C3N-00200-02	Tumor	No	C3N-00200	CPT0017870006	CPT0017870006.WholeExome.RP-1303.bam	84bbba11-564e-4318-9958-7e1f5f976431	Primary_Tumor	CPT0028400002	CPT0028400002.WholeExome.RP-1303.bam	b44d5974-852f-4a89-9412-9c321bf1d1a9	Blood_Derived_Normal	CPT0017870009	C3N-00200	Primary Tumor	c9c50554-d2cc-4a32-a115-38a396a175f3	170823_UNC31-K00269_0075_AHLCW5BBXX_AGTTCC_S22_L006_R1_001.fastq.gz	95fff05f-06dc-4463-a6b9-9cb88669fe24	170823_UNC31-K00269_0075_AHLCW5BBXX_AGTTCC_S22_L006_R2_001.fastq.gz	C3N-00200	NA	NA	4 or more	9	IIIC1	Not identified	Stage III	Yes	46.85	1	NA	72	0.157712493	0	0	0	0	0.189955698	0.007935982	0.030101489	0	0.042572483	0.052652388	0	0	0.00647704	0.013428672	0.074472037	0	0.6	0	0	0	0.024691718	0	0.003404556	0.080478688	0.437720749	0.370392479	0.034985182	1.24E-08	0.003404118	0.069614216	4838.564981	4684.861932	9523.426913	0.708	-0.204	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	NA	normal
S059	CPT0010260003	C3N-00321	3	10	130N	C3N-00321-01	Tumor	Yes	C3N-00321	CPT0010260006	CPT0010260006.WholeExome.RP-1303.bam	5c324ae6-3212-436b-a15f-da22617a00ee	Primary_Tumor	CPT0010380002	CPT0010380002.WholeExome.RP-1303.bam	4618c73c-21c1-45a5-8354-40b8d85a82e5	Blood_Derived_Normal	CPT0010260013	C3N-00321	Primary Tumor	0de8cfbb-adb2-4d1d-91f6-685a03b16449	170802_UNC31-K00269_0072_AHK3GVBBXX_ATCACG_S21_L007_R1_001.fastq.gz	cc11b6d3-897f-4158-96a4-91b5ebbbb74e	170802_UNC31-K00269_0072_AHK3GVBBXX_ATCACG_S21_L007_R2_001.fastq.gz	C3N-00321	NA	Serous carcinoma	2	1.5	IA	under 50 %	Stage I	No	26	0	NA	64	0.303072564	0.046680774	0.001645347	0	0.099611915	0.207091546	0	0	0	0.038086734	0.073224264	0	0	0.043384893	0.120657123	0.098087625	0	1.12	0	0.054679848	0	0.033777368	0	0.007932213	0.081580986	0.076065268	0.650271851	0.043301072	1.06E-09	0.003773438	0.137075172	6229.435198	3627.437843	9856.873041	-1.89	0.609	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSI-H	WT	NA	normal
S060	CPT0010430003	C3N-00322	1	4	130C	C3N-00322-03	Tumor	Yes	C3N-00322	CPT0010430006	CPT0010430006.WholeExome.RP-1303.bam	799392c1-a0d2-420b-8743-7923c6b3e65d	Primary_Tumor	CPT0077050001	CPT0077050001.WholeExome.RP-1303.bam	af241383-48c7-4492-8b90-c16b3fe72e2d	Blood_Derived_Normal	CPT0010430009	C3N-00322	Primary Tumor	86f3b033-6491-4d96-bf41-f51ddfc6bb5b	170818_UNC32-K00270_0050_AHL2FHBBXX_ATCACG_S5_L008_R1_001.fastq.gz	258cde18-4abd-4a5f-8140-23f1da45abdc	170818_UNC32-K00270_0050_AHL2FHBBXX_ATCACG_S5_L008_R2_001.fastq.gz	C3N-00322	NA	Serous carcinoma	2	2.6	IA	under 50 %	Stage I	No	31	0	0	70	0.034506425	0.002492303	0	0	0.0009	0.047962606	0	0	0.007519195	0.008844079	0.010084213	0	0	0.029447879	0.001711434	0.024497424	0	0.2	0	0	0	0.032059529	0	0.004036411	0.038672923	0.022281501	0.801921196	0.03878787	2.01E-09	0.001245467	0.093054629	3671.485686	2569.07483	6240.560516	-0.023	0.295	0	1	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Serous carcinoma	normal
S061	CPT0010610003	C3N-00323	2	7	130C	C3N-00323-02	Tumor	Yes	C3N-00323	CPT0010610006	CPT0010610006.WholeExome.RP-1303.bam	02c2e0f0-0f10-4f0c-91cf-15763338f0cf	Primary_Tumor	CPT0010760002	CPT0010760002.WholeExome.RP-1303.bam	3db8c0a1-bd86-4421-b9f7-c03931cf68fd	Blood_Derived_Normal	CPT0010610009	C3N-00323	Primary Tumor	6c14578c-92ff-4085-a8d8-d5122ff4fd11	170818_UNC32-K00270_0050_AHL2FHBBXX_CGATGT_S6_L008_R1_001.fastq.gz	727a9891-1116-4c77-9787-a08111f0b3e8	170818_UNC32-K00270_0050_AHL2FHBBXX_CGATGT_S6_L008_R2_001.fastq.gz	C3N-00323	NA	Serous carcinoma	NA	4	IA	under 50 %	Stage I	No	27	0	NA	78	0.140721701	0	0.011763169	0	0.037899661	0.153705136	0	0	0.184708541	0	0	0	0	0.029467374	0	0.068410488	0	0.71	0	0	0.037773189	0.045550741	0	0.006382884	0.12871576	0.061490059	0.601661375	0.050010993	4.63E-09	0.002939082	0.148799843	5246.146449	3740.58003	8986.72648	-1.78	0.5	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Serous carcinoma	normal
S062	CPT0010820003	C3N-00324	3	11	130C	C3N-00324-04	Tumor	Yes	C3N-00324	CPT0010820006	CPT0010820006.WholeExome.RP-1303.bam	8e136610-d0b3-4cb7-9255-864fc245c501	Primary_Tumor	CPT0010950002	CPT0010950002.WholeExome.RP-1303.bam	076629d4-e94a-4038-b307-a739802370c1	Blood_Derived_Normal	CPT0010820009	C3N-00324	Primary Tumor	a76e636b-9fd0-4cf2-b0c6-78ed366d7c3d	170818_UNC32-K00270_0050_AHL2FHBBXX_TTAGGC_S21_L008_R1_001.fastq.gz	ced11262-32d0-42c6-a91f-2d3f801ed551	170818_UNC32-K00270_0050_AHL2FHBBXX_TTAGGC_S21_L008_R2_001.fastq.gz	C3N-00324	FIGO grade 2	Endometrioid carcinoma	NA	2.3	II	50 % or more	Stage II	Yes	35	0	NA	66	0.292386957	0.065752505	0.002204626	0.045348883	0.019022007	0.182363781	0.049617216	0.013078051	0.045221132	0.01866044	0.018403697	0	0	0.001911367	0.014451686	0	0	0.81	0.010695738	0	0.017253413	0	0.013628498	0.004926435	0.046900078	0.040904304	0.738513065	0.039417667	6.37E-09	0.006079859	0.123258586	6318.746917	3563.533329	9882.280246	-0.254	0.266	0	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S063	CPT0022530003	C3N-00326	2	8	130C	C3N-00326-01	Tumor	Yes	C3N-00326	CPT0022530006	CPT0022530006.WholeExome.RP-1303.bam	b2a6131b-ac34-46fc-a70e-709411f20121	Primary_Tumor	CPT0019690002	CPT0019690002.WholeExome.RP-1303.bam	ce1d5839-15dd-43bd-9ccd-faf8924ccc92	Blood_Derived_Normal	CPT0022530009	C3N-00326	Primary Tumor	fd7cf324-b89a-4558-a03f-d64ef2be88ff	170823_UNC31-K00269_0075_AHLCW5BBXX_GATCAG_S8_L008_R1_001.fastq.gz	90917b44-0072-4cec-bd84-9dd8885045f0	170823_UNC31-K00269_0075_AHLCW5BBXX_GATCAG_S8_L008_R2_001.fastq.gz	C3N-00326	FIGO grade 1	Endometrioid carcinoma	2	1.3	IA	Not identified	Stage I	No	35	0	0	45	0.113361734	0.011314816	0.004202812	0.01927318	0.002384896	0.053377612	0.021351223	0	0.087850691	0	0	0	0	0.024248712	0.001274594	0.040886712	0	0.44	0.001495829	0	0.034001026	0	0.024953588	0.004979518	0.044211258	0.065285664	0.7445788	0.041874395	5.17E-10	0.001658171	0.097412193	3796.214544	1840.583053	5636.797597	0.179	-1.17	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S064	CPT0019840003	C3N-00328	3	12	130C	C3N-00328-05	Tumor	Yes	C3N-00328	CPT0019840009	CPT0019840009.WholeExome.RP-1303.bam	57ca5aaa-f52d-46f0-adb6-9cae7b4afeab	Primary_Tumor	CPT0020410002	CPT0020410002.WholeExome.RP-1303.bam	ff4dbd26-ddd1-43ca-96b9-7b4b849268b6	Blood_Derived_Normal	CPT0019840006	C3N-00328	Primary Tumor	1409ef12-3919-4b88-b5b8-4a85576fadc7	170818_UNC32-K00270_0051_BHLCCHBBXX_GCCAAT_S16_L004_R1_001.fastq.gz	fba3daa2-3a66-4af6-aa02-ff5cb8d534eb	170818_UNC32-K00270_0051_BHLCCHBBXX_GCCAAT_S16_L004_R2_001.fastq.gz	C3N-00328	FIGO grade 3	Endometrioid carcinoma	NA	3	IB	50 % or more	Stage I	No	31.22	0	NA	62	0.103577841	0.004733789	0	0	0.194001873	0.285098088	0	0	0.063637704	0.003230715	0	0.263662345	0	0.091752351	0.083597209	0.16848275	0	1.35	0	0.004897877	0.080428803	0.002898656	0	0.014894189	0.041931867	0.031289689	0.720007478	0.043499463	6.15E-10	0.012644167	0.135733147	9711.938731	4369.682108	14081.62084	-0.927	-0.565	0	0	1	1	0	0	0	0	1	1	0	1	1	1	0	1	1	1	1	MSS	Mutated	Endometrioid carcinoma	normal
S065	CPT0011000003	C3N-00333	2	5	127N	C3N-00333-03	Tumor	Yes	C3N-00333	CPT0011000006	CPT0011000006.WholeExome.RP-1303.bam	9deb7257-8b5f-4f3a-81f5-13f84026f6f9	Primary_Tumor	CPT0011100002	CPT0011100002.WholeExome.RP-1303.bam	59cf4caf-2c41-4390-93cf-51f4dbeef3af	Blood_Derived_Normal	CPT0011000009	C3N-00333	Primary Tumor	46b971bf-81ed-4c18-9272-3e65823123e2	170818_UNC32-K00270_0050_AHL2FHBBXX_TGACCA_S22_L008_R1_001.fastq.gz	ae764c5a-f0ca-4a2e-b08e-ef1a65ddfe20	170818_UNC32-K00270_0050_AHL2FHBBXX_TGACCA_S22_L008_R2_001.fastq.gz	C3N-00333	NA	Serous carcinoma	NA	1	IA	under 50 %	Stage I	No	31	0	NA	65	0.069356038	0.01672796	0	0.0009	0.008736583	0.090772415	0.022602173	0.051333479	0.093244702	0.016298314	0.020033554	0	0	0.00704365	0.009639726	0.01497689	0	0.52	0	0.047553185	0	0.050744634	0	0.002296699	0.111089441	0.118953119	0.629962672	0.03362146	1.15E-09	0.00527552	0.098801088	6014.318353	5520.164395	11534.48275	-0.608	-0.353	0	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Serous carcinoma	normal
S066	CPT0018570003	C3N-00334	4	14	129C	C3N-00334-02	Tumor	Yes	C3N-00334	CPT0018570006	CPT0018570006.WholeExome.RP-1303.bam	8f11fde6-a7f1-47bc-acb8-b441627fc49b	Primary_Tumor	CPT0018720002	CPT0018720002.WholeExome.RP-1303.bam	698bdc5a-57cd-446d-999d-d4982ebb1904	Blood_Derived_Normal	CPT0018570009	C3N-00334	Primary Tumor	d92fcd95-f416-4785-aca7-f8c53a3099b1	170818_UNC32-K00270_0050_AHL2FHBBXX_GGCTAC_S14_L006_R1_001.fastq.gz	18275a18-20bd-45fc-af1e-e340d86a97c6	170818_UNC32-K00270_0050_AHL2FHBBXX_GGCTAC_S14_L006_R2_001.fastq.gz	C3N-00334	NA	Serous carcinoma	1	1.4	IA	under 50 %	Stage I	No	32.83	0	NA	68	0.207054009	0.049886437	0	0.001940573	0.013020446	0.127467118	0.009914774	0.009016892	0.036097355	0.045750101	0.009842251	0	0	0.040284527	0.02143719	0.01546921	0	0.62	0	0	0.019796059	0	0.013023059	0.005235246	0.062289497	0.058682364	0.714983821	0.034217712	6.69E-07	0.003675535	0.120915156	5108.003671	3171.067885	8279.071556	0.439	0.342	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSI-H	WT	NA	normal
S067	CPT0018790003	C3N-00335	2	8	130N	C3N-00335-05	Tumor	Yes	C3N-00335	CPT0018790006	CPT0018790006.WholeExome.RP-1303.bam	d557066f-c9ff-4d82-b010-b89d1da90aca	Primary_Tumor	CPT0018910002	CPT0018910002.WholeExome.RP-1303.bam	50bc0004-e7a5-480b-b488-d85d405a3c0e	Blood_Derived_Normal	CPT0018790009	C3N-00335	Primary Tumor	ed41b710-e03a-402f-a5f5-7edd980641ae	170818_UNC32-K00270_0050_AHL2FHBBXX_CTTGTA_S13_L006_R1_001.fastq.gz	71b23a8a-c3a4-4c35-bb58-f03e9e6d8da0	170818_UNC32-K00270_0050_AHL2FHBBXX_CTTGTA_S13_L006_R2_001.fastq.gz	C3N-00335	NA	Serous carcinoma	None	2.5	IA	under 50 %	Stage I	No	29.52	0	NA	57	0.094326881	0	0	0.009113625	0.077466078	0.174081384	0	0.0004	0.042293294	0.037397016	0.035347052	0.097293058	0	0.016467675	0.024431161	0.129747623	0	0.79	0	0	0.01531505	0	0.036358248	0.009399873	0.060392349	0.073173287	0.698915258	0.01668522	1.04E-10	0.008031966	0.133402048	8381.068241	5147.204936	13528.27318	-1.63	-2.33	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	NA	normal
S068	CPT0018960003	C3N-00337	1	4	131	C3N-00337-04	Tumor	Yes	C3N-00337	CPT0018960006	CPT0018960006.WholeExome.RP-1303.bam	98c496b5-ba13-40d1-88ca-c83251d259ea	Primary_Tumor	CPT0019100002	CPT0019100002.WholeExome.RP-1303.bam	94c8c234-c469-4230-a494-dd6129561aa4	Blood_Derived_Normal	CPT0018960013	C3N-00337	Primary Tumor	2ed2fd9d-d69e-4924-bcac-555bfa24030e	170818_UNC32-K00270_0050_AHL2FHBBXX_CCGTCC_S7_L005_R1_001.fastq.gz	6d9108cf-e7d8-4040-8e1d-3f707ee381c8	170818_UNC32-K00270_0050_AHL2FHBBXX_CCGTCC_S7_L005_R2_001.fastq.gz	C3N-00337	NA	Serous carcinoma	1	1.3	IB	50 % or more	Stage I	No	29.07	0	NA	67	0.111390552	0	0	0.015226148	0.004766039	0.092418353	0.081958621	0.011103314	0.016427891	0	0	0	0	0.043745649	0.007989276	0.016943114	0	0.43	0	0	0.02417088	0.003860163	0	0.005483621	0.105357622	0.054561115	0.680690877	0.03552117	5.75E-10	0.001150593	0.117235002	3551.918217	2317.879694	5869.797912	-1.82	-0.718	0	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Serous carcinoma	normal
S069	CPT0020530003	C3N-00339	2	6	131	C3N-00339-02	Tumor	Yes	C3N-00339	CPT0020530009	CPT0020530009.WholeExome.RP-1303.bam	8d561558-33a7-43ce-82ee-16393ac3aa86	Primary_Tumor	CPT0020600002	CPT0020600002.WholeExome.RP-1303.bam	4073402b-0ed8-45ed-a6fa-e53758b6a568	Blood_Derived_Normal	CPT0020530006	C3N-00339	Primary Tumor	b583347d-5091-47aa-88f4-f13b6ccdbc9b	170818_UNC32-K00270_0051_BHLCCHBBXX_CAGATC_S9_L003_R1_001.fastq.gz	fb5ba732-fdb9-4fb1-a189-ca27dc978cfd	170818_UNC32-K00270_0051_BHLCCHBBXX_CAGATC_S9_L003_R2_001.fastq.gz	C3N-00339	FIGO grade 2	Endometrioid carcinoma	NA	1.3	IA	under 50 %	Stage I	No	21.83	0	0	45	0.151782648	0.001005253	0	0.0284594	0.023516134	0.088148927	0.032505502	0	0.052651407	0	0.026200573	0	0.003299952	0.019515459	0.018158207	0.008406152	0	0.55	0.0008	0	0	0	0.095529589	0.008953555	0.065979471	0.084386617	0.593816436	0.039508302	5.75E-08	0.003261892	0.20409367	6024.521674	3770.318861	9794.840535	0.275	-1.17	0	1	0	0	0	0	0	0	1	1	0	0	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S070	CPT0022620003	C3N-00340	3	10	128C	C3N-00340-03	Tumor	Yes	C3N-00340	CPT0022620006	CPT0022620006.WholeExome.RP-1303.bam	4a86747f-73ce-4f96-99c0-5dbf356dc061	Primary_Tumor	CPT0020710002	CPT0020710002.WholeExome.RP-1303.bam	dd13ec1a-c913-4f22-803c-055eb8e583f6	Blood_Derived_Normal	CPT0022620009	C3N-00340	Primary Tumor	9c6560e4-984b-4de4-b784-06e2d358ee2d	170823_UNC31-K00269_0075_AHLCW5BBXX_GTCCGC_S23_L006_R1_001.fastq.gz	b3de2a7e-ac96-42dd-bcf2-61f14df637c6	170823_UNC31-K00269_0075_AHLCW5BBXX_GTCCGC_S23_L006_R2_001.fastq.gz	C3N-00340	NA	Serous carcinoma	2	3.5	IIIC1	under 50 %	Stage III	No	27	1	NA	60	0.135062253	0.017311522	0	0.008671362	0.065229078	0.180950468	0	0.006634182	0.083981574	0.010986849	0.095799524	0	0	0.010129747	0.052257959	0.119573197	0	0.86	0.0004	0	0	0	0.073013728	0.0067689	0.078487444	0.068433718	0.698859525	0.010548701	2.45E-09	0.006156781	0.130744929	7879.766432	4660.078921	12539.84535	-2.36	-1.58	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S071	CPT0021650003	C3N-00377	4	14	130N	C3N-00377-02	Tumor	Yes	C3N-00377	CPT0021650009	CPT0021650009.WholeExome.RP-1303.bam	eecca0a0-8639-4107-b6f1-1f49b32a5b0e	Primary_Tumor	CPT0021710002	CPT0021710002.WholeExome.RP-1303.bam	bd05fb6c-0e21-451f-a377-bb10488c537e	Blood_Derived_Normal	RNAseq_C3N-00377_primary_tumor	C3N-00377	Primary Tumor	927fd63f-62e5-491b-8c64-bdb58cb0881c	171011_UNC31-K00269_0086_AHLJLCBBXX_GTGGCC_S8_L003_R1_001.fastq.gz	bc45d610-dace-4837-a41d-4a4ea3cb8b5c	171011_UNC31-K00269_0086_AHLJLCBBXX_GTGGCC_S8_L003_R2_001.fastq.gz	C3N-00377	FIGO grade 2	Endometrioid carcinoma	NA	1	IA	under 50 %	Stage I	Yes	34	0	0	64	0.09073604	0.00618781	0	0.1185783	0.004394117	0.028277497	0.023606374	0	0.087639399	0	0.008723851	0	0	0.007937663	0.019611349	0	0	0.53	0.023100596	0	0.001813999	0	0.109393005	0.004000451	0.050668927	0.018259117	0.830504353	0.026465241	4.65E-10	0.001646215	0.068455696	4260.000421	1368.770354	5628.770775	-0.642	0.0175	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S072	CPT0015520003	C3N-00379	3	9	129N	C3N-00379-01	Tumor	Yes	C3N-00379	CPT0015520009	CPT0015520009.WholeExome.RP-1303.bam	46cbd86d-ddfa-45c8-b52c-22f641f1e678	Primary_Tumor	CPT0015740002	CPT0015740002.WholeExome.RP-1303.bam	30ee48c9-4925-4d05-a7b4-23f0e18813f8	Blood_Derived_Normal	CPT0015520006	C3N-00379	Primary Tumor	8b3b442d-0e88-4e6c-84b0-b4eaae2be844	170823_UNC31-K00269_0076_BHLCTFBBXX_ATTCCT_S1_L001_R1_001.fastq.gz	9c1db68b-16f9-42cd-b818-cd95a5236e11	170823_UNC31-K00269_0076_BHLCTFBBXX_ATTCCT_S1_L001_R2_001.fastq.gz	C3N-00379	FIGO grade 2	Endometrioid carcinoma	1	2.5	IA	under 50 %	Stage I	No	36.81	0	0	41	0.218420192	0.086513328	0.017933064	0	0.023567338	0.151485066	0.0015387	0.026199623	0.01902837	0.0009	0.02064572	0	0	0.004338932	0.00995094	0.071564429	0	0.7	0.007938323	0	0.026913005	0.013040807	0	0.003503154	0.140659271	0.245873229	0.485333012	0.031302276	1.45E-08	0.003490464	0.08983858	5698.605048	4548.865546	10247.47059	0.639	-0.337	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S073	CPT0022830003	C3N-00383	1	2	129N	C3N-00383-04	Tumor	Yes	C3N-00383	CPT0022830006	CPT0022830006.WholeExome.RP-1303.bam	5c4a506f-3e9f-48bc-9013-89232633f467	Primary_Tumor	CPT0020790002	CPT0020790002.WholeExome.RP-1303.bam	26faf9ae-c14f-4bae-b84b-4b0ca9c0161b	Blood_Derived_Normal	CPT0022830009	C3N-00383	Primary Tumor	d8669320-5d71-4398-b65c-26c820c08fbf	170823_UNC31-K00269_0075_AHLCW5BBXX_GATCAG_S8_L002_R1_001.fastq.gz	d98e6375-44c4-45d8-a771-293f086bc52b	170823_UNC31-K00269_0075_AHLCW5BBXX_GATCAG_S8_L002_R2_001.fastq.gz	C3N-00383	FIGO grade 1	Endometrioid carcinoma	1	4	IA	under 50 %	Stage I	No	46	0	0	61	0.096250531	0.005855964	0	0	0	0.083600371	0.010619227	0.014863803	0	0	0.011322581	0	0.008617884	0.015359593	0.0026438	0.039137254	0	0.34	0.025684679	0	0	0.026044313	0	0.005384921	0.132889331	0.094470153	0.612824268	0.055027196	7.50E-09	0.001412001	0.097992123	3325.590092	3237.700172	6563.290264	-0.525	-0.0362	0	0	0	0	0	1	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S074	CPT0016220003	C3N-00386	3	9	130C	C3N-00386-02	Tumor	Yes	C3N-00386	CPT0016220009	CPT0016220009.WholeExome.RP-1303.bam	ccff87e8-bc7f-48af-b325-d7a4dfd834a1	Primary_Tumor	CPT0016770002	CPT0016770002.WholeExome.RP-1303.bam	8e993334-64df-4f09-b9b3-55487d9af4a8	Blood_Derived_Normal	CPT0016220006	C3N-00386	Primary Tumor	68aa44a5-d2a6-4ba3-ba6c-0650d6f945f4	170823_UNC31-K00269_0076_BHLCTFBBXX_ATCACG_S4_L001_R1_001.fastq.gz	c5af6b28-5fc3-4a17-bb93-bceb731d1f80	170823_UNC31-K00269_0076_BHLCTFBBXX_ATCACG_S4_L001_R2_001.fastq.gz	C3N-00386	FIGO grade 1	Endometrioid carcinoma	2	2.3	IA	under 50 %	Stage I	No	27.31	0	0	44	0.21779436	0.025064852	0	0	0.019426868	0.129435366	0.016131815	0	0.017185208	0.011563794	0.017937373	0	0	0.002019326	0.075026311	0.077080519	0	0.65	0	0	0	0.041334208	0	0.003464145	0.075680425	0.124031449	0.635227781	0.053395146	4.21E-09	0.002052767	0.106148283	5415.732444	3739.873076	9155.605519	-0.0734	-0.106	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S075	CPT0016940003	C3N-00388	4	13	129N	C3N-00388-01	Tumor	Yes	C3N-00388	CPT0016940008	CPT0016940008.WholeExome.RP-1303.bam	552275c4-18b2-4901-91ee-8abe9ad2f896	Primary_Tumor	CPT0017290002	CPT0017290002.WholeExome.RP-1303.bam	61696290-2092-4f8d-9abb-a93ace3dd6bb	Blood_Derived_Normal	CPT0016940006	C3N-00388	Primary Tumor	c6980525-d030-4169-9393-0f1f73fe04a8	170823_UNC31-K00269_0076_BHLCTFBBXX_AGTTCC_S19_L005_R1_001.fastq.gz	a989c255-f970-475b-bd15-7b7103241d2a	170823_UNC31-K00269_0076_BHLCTFBBXX_AGTTCC_S19_L005_R2_001.fastq.gz	NA	NA	Serous carcinoma	1	4	IA	under 50 %	Stage I	No	20.55	0	NA	59	0.164865609	0	0.0094154	0.011317526	0.024603135	0.112311231	0.004934959	0.011249512	0.058283669	0	0.002314538	0	0	0.030300705	0.027823669	0.021893216	0	0.55	0	0	0.030943857	0	0.039742974	0.004485592	0.061969134	0.052902816	0.739647742	0.032607874	3.06E-09	0.002609858	0.105776981	5071.823771	2390.647801	7462.471572	-1.32	-0.242	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSI-H	WT	NA	normal
S076	CPT0026270003	C3N-00389	1	3	131	C3N-00389-04	Tumor	Yes	C3N-00389	CPT0026270009	CPT0026270009.WholeExome.RP-1303.bam	651675eb-c88d-4b89-a21e-f5bcfd44cc5a	Primary_Tumor	CPT0026370002	CPT0026370002.WholeExome.RP-1303.bam	b6edfded-46d9-4fe0-b25d-d956b242dfc5	Blood_Derived_Normal	CPT0026270006	C3N-00389	Primary Tumor	dd9cffde-1af6-49c4-b230-6b68529c0cab	170828_UNC31-K00269_0077_AHLF33BBXX_ATCACG_S15_L007_R1_001.fastq.gz	0a029fc1-cddc-482f-8d17-f1aee87e877f	170828_UNC31-K00269_0077_AHLF33BBXX_ATCACG_S15_L007_R2_001.fastq.gz	C3N-00389	FIGO grade 2	Endometrioid carcinoma	1	1.5	IB	50 % or more	Stage I	No	17.85	0	0	62	0.124816275	0.011178091	0.01092673	0	0.0433648	0.219421538	0	0	0.157369678	0	0.014971624	0.053681598	0.014679488	0.070557933	0.108819909	0.149854695	0	0.99	0	0	0	0.010357642	0	0.012965305	0.065170953	0.07740866	0.67280721	0.038402581	1.44E-09	0.005576804	0.127668486	6780.561618	3323.981653	10104.54327	-1.22	-0.628	0	1	0	0	1	0	0	0	1	1	0	0	1	0	0	1	1	0	1	MSI-H	WT	Endometrioid carcinoma	normal
S077	CPT0064930004	C3N-00729	2	6	128C	"C3N-00729-02,C3N-00729-03"	Tumor	No	C3N-00729	CPT0064930010	CPT0064930010.WholeExome.RP-1303.bam	b52bc4e8-6556-42fb-b355-3a3a7ed55e45	Primary_Tumor	CPT0070650002	CPT0070650002.WholeExome.RP-1303.bam	2f910f19-f0a4-43b5-aa6f-e257abda54ca	Blood_Derived_Normal	CPT0064930007	C3N-00729	Primary Tumor	2c0420b6-8299-46ed-8971-deab6b23eabf	170823_UNC31-K00269_0075_AHLCW5BBXX_CCGTCC_S20_L006_R1_001.fastq.gz	f783684d-96e1-46be-a19e-686d53adf650	170823_UNC31-K00269_0075_AHLCW5BBXX_CCGTCC_S20_L006_R2_001.fastq.gz	C3N-00729	FIGO grade 2	Endometrioid carcinoma	4 or more	4	IB	50 % or more	Stage II	No	29.62	0	0	86	0.081380422	0	0.006463702	0.059587641	0.007387838	0.124292888	0	0	0.304649896	0.00168362	0.019284594	0	0.019373833	0.033097091	0.020752246	0.020138707	0	0.76	0	0	0	0	0.061907521	0.006626794	0.108277744	0.072052749	0.691679134	0.013685766	3.78E-09	0.008524373	0.099153436	6798.100266	4279.438113	11077.53838	-1.8	-0.543	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S078	CPT0026030004	C3N-00734	1	1	130N	"C3N-00734-01,C3N-00734-03"	Tumor	No	C3N-00734	CPT0026030010	CPT0026030010.WholeExome.RP-1303.bam	51a2d1b9-cfa4-4dee-8422-a3d360c47bd6	Primary_Tumor	CPT0028500002	CPT0028500002.WholeExome.RP-1303.bam	e47c2ca6-cc2b-4d41-a788-21a8419bb2d5	Blood_Derived_Normal	CPT0026030007	C3N-00734	Primary Tumor	9faa7052-ed20-4706-97f2-c3f183a4a0bd	170912_UNC31-K00269_0081_AHL3YKBBXX_ACAGTG_S7_L002_R1_001.fastq.gz	4518b21b-b9a3-4261-b0e1-27b9f7d0e282	170912_UNC31-K00269_0081_AHL3YKBBXX_ACAGTG_S7_L002_R2_001.fastq.gz	C3N-00734	FIGO grade 1	Endometrioid carcinoma	None	4	IIIA	50 % or more	Stage III	No	38.97	1	NA	53	0.136729657	0.009838939	0.001303502	0.072578025	0	0.097929766	0.015000539	0	0.011028416	0	0.069134349	0	0.006524058	0	0.014417241	0.016723849	0	0.58	0	0	0	0	0.128791658	0.005026187	0.131855933	0.061861318	0.66406077	0.027766592	4.41E-09	0.003653403	0.105775791	5784.902177	2750.595162	8535.497339	-0.528	-0.388	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S079	CPT0062940003	C3N-00743	3	12	128N	C3N-00743-01	Tumor	No	C3N-00743	CPT0062940009	CPT0062940009.WholeExome.RP-1303.bam	7d110913-430e-457f-94e5-e2bd1af6cb90	Primary_Tumor	CPT0063060002	CPT0063060002.WholeExome.RP-1303.bam	32b28c13-d52e-44cb-8100-d212f1eaaa86	Blood_Derived_Normal	CPT0062940006	C3N-00743	Primary Tumor	a7609db0-2819-4dc0-9988-4a1323d15135	170823_UNC31-K00269_0076_BHLCTFBBXX_CTTGTA_S13_L004_R1_001.fastq.gz	b10f3be4-53ec-4526-96d5-050e3a0eebe7	170823_UNC31-K00269_0076_BHLCTFBBXX_CTTGTA_S13_L004_R2_001.fastq.gz	C3N-00743	FIGO grade 2	Endometrioid carcinoma	2	3.5	IA	under 50 %	Stage I	No	48.46	0	0	53	0.160050801	0	0.013355372	0	0	0.03309009	0.015563506	0.020732476	0.013521662	0.010998418	0.009230714	0	0	0.038080912	0.024640361	0.046626728	0	0.44	0	0	0.033115855	0.020993106	0	0.004039392	0.149448996	0.168628647	0.56258982	0.035878962	6.88E-09	0.000433903	0.078980272	2870.606208	2616.128221	5486.734429	-0.298	-0.659	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S080	CPT0023810003	C3N-00836	2	6	130C	C3N-00836-02	Tumor	Yes	C3N-00836	CPT0023810009	CPT0023810009.WholeExome.RP-1303.bam	885e2d3a-b405-444f-9657-32e7aba0d450	Primary_Tumor	CPT0023910002	CPT0023910002.WholeExome.RP-1303.bam	7cd78b8b-aa8b-4319-a7a2-a0116fdb5cf3	Blood_Derived_Normal	CPT0023810006	C3N-00836	Primary Tumor	f19c6938-942c-47bd-b72d-79d62e8fbeb8	170912_UNC31-K00269_0081_AHL3YKBBXX_TTAGGC_S6_L008_R1_001.fastq.gz	5c51da7e-eead-4fd1-8343-c4d4ddc19458	170912_UNC31-K00269_0081_AHL3YKBBXX_TTAGGC_S6_L008_R2_001.fastq.gz	C3N-00836	NA	Serous carcinoma	3	1	IA	under 50 %	Stage I	No	30.47	0	NA	75	0.003827364	0	0	0.031045659	0.306262844	0.443728427	0	0	0.175928867	0.04942716	0.054696075	0.503309554	0.016317124	0.031350984	0.159976185	0.63289952	0	2.5	0	0	0.056594181	0	0.034636055	0.018025928	0.114536976	0.039861707	0.607348151	0.045724267	2.09E-09	0.011478385	0.163024583	9583.565561	5319.12579	14902.69135	-2.21	-1.16	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S081	CPT0027650003	C3N-00847	4	16	130C	C3N-00847-01	Tumor	Yes	C3N-00847	CPT0027650009	CPT0027650009.WholeExome.RP-1303.bam	727f7adb-b3b8-4cc4-b732-a1c1355ed9d9	Primary_Tumor	CPT0027740002	CPT0027740002.WholeExome.RP-1303.bam	bba06639-667d-4675-808d-fbb4ebe45a64	Blood_Derived_Normal	CPT0027650006	C3N-00847	Primary Tumor	a3c73a24-ad46-4690-a782-0c9de7554f6b	170830_UNC31-K00269_0078_AHLCVMBBXX_CGATGT_S6_L002_R1_001.fastq.gz	33715f26-60b2-4c5d-994c-00faa767e9be	170830_UNC31-K00269_0078_AHLCVMBBXX_CGATGT_S6_L002_R2_001.fastq.gz	C3N-00847	FIGO grade 2	Endometrioid carcinoma	2	4.3	IIIA	under 50 %	Stage III	No	34.53	0	NA	65	0.081197741	0	0.056220642	0.002014424	0.007473355	0	0.007590874	0	0.170651046	0	0	0	0	0.010732175	0	0.053007557	0	0.43	0	0	0.008729727	0.032382459	0	0.005454982	0.06545845	0.040036596	0.743653544	0.053361059	2.07E-09	0.000828178	0.091207189	2157.90896	1325.965485	3483.874446	-0.425	0.328	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S082	CPT0024130003	C3N-00848	4	15	130C	C3N-00848-02	Tumor	Yes	C3N-00848	CPT0024130009	CPT0024130009.WholeExome.RP-1303.bam	b2994b0c-76e6-4340-9c95-8ea82b66ef61	Primary_Tumor	CPT0024210002	CPT0024210002.WholeExome.RP-1303.bam	2a32d47a-5ab8-48d7-9992-5f7294ffbfae	Blood_Derived_Normal	CPT0024130006	C3N-00848	Primary Tumor	6e88806d-df9b-40b0-9ab9-d5f5265ef294	170912_UNC31-K00269_0081_AHL3YKBBXX_GTGGCC_S3_L001_R1_001.fastq.gz	b8f22b8f-204c-48b4-8147-5c9caf3c2f76	170912_UNC31-K00269_0081_AHL3YKBBXX_GTGGCC_S3_L001_R2_001.fastq.gz	C3N-00848	FIGO grade 2	Endometrioid carcinoma	None	3	IA	under 50 %	Stage I	Yes	33.65	0	0	66	0.141768576	0	0.0262358	0.028468981	0.011451255	0.099516218	0.009602334	0.009388966	0.037858222	0	0.055392899	0	0.009631275	0.078532432	0.030498309	0.061654733	0	0.6	0	0	0	0	0	0.006741019	0.059487435	0.046914004	0.711541498	0.04025961	1.58E-09	0.00231511	0.132741322	4772.594927	2236.194057	7008.788984	0.399	0.436	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S083	CPT0027810003	C3N-00850	1	1	131	C3N-00850-02	Tumor	Yes	C3N-00850	CPT0027810009	CPT0027810009.WholeExome.RP-1303.bam	f2f2bd5a-3cab-4f68-92cc-945f1c2e2fac	Primary_Tumor	CPT0027890002	CPT0027890002.WholeExome.RP-1303.bam	e7b4e3d1-b988-4a96-a361-2fa1698e1676	Blood_Derived_Normal	CPT0027810006	C3N-00850	Primary Tumor	232956d9-bea5-47c0-8fcb-bfbbb8bab7e5	170912_UNC31-K00269_0081_AHL3YKBBXX_AGTTCC_S19_L005_R1_001.fastq.gz	23941127-4227-4b4a-82ea-f76fe7062763	170912_UNC31-K00269_0081_AHL3YKBBXX_AGTTCC_S19_L005_R2_001.fastq.gz	C3N-00850	FIGO grade 2	Endometrioid carcinoma	1	1	IA	under 50 %	Stage I	No	28.84	0	0	65	0.098042625	0.0002	0.028484946	0	0.066989651	0.174223788	0	0.002629565	0.095029079	0	0.048861303	0	0	0.055544593	0.05726203	0.191800595	0	0.84	0	0	0	0.020947178	0	0.005502748	0.079296536	0.082280026	0.681858696	0.041651211	1.08E-09	0.004117287	0.105293495	5804.812736	3142.491368	8947.304105	1.36	0.806	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S084	CPT0078320004	C3N-00858	1	1	127N	"C3N-00858-01,C3N-00858-04"	Tumor	No	C3N-00858	CPT0078320010	CPT0078320010.WholeExome.RP-1303.bam	6fa84d36-167b-43b7-b63d-5a6acc4ef00f	Primary_Tumor	CPT0078420002	CPT0078420002.WholeExome.RP-1303.bam	47249bc4-3efc-4e44-970a-0542ab7f1baf	Blood_Derived_Normal	CPT0078320007	C3N-00858	Primary Tumor	1a17a35c-466d-4a23-aee2-04b09c784e2a	170830_UNC31-K00269_0078_AHLCVMBBXX_AGTCAA_S18_L006_R1_001.fastq.gz	1a561b74-0af0-4d52-9288-9fa08c5d2729	170830_UNC31-K00269_0078_AHLCVMBBXX_AGTCAA_S18_L006_R2_001.fastq.gz	C3N-00858	FIGO grade 2	Endometrioid carcinoma	2	11	IIIB	50 % or more	Stage III	No	36	1	NA	65	0.058394539	0	0.005921685	0	0.009653509	0.094545911	0	0	0.099516789	0	0	0	0.013644085	0.039926845	0.010287635	0.055865002	0	0.44	0	0.004284004	0	0.047959996	0	0.008642722	0.07255053	0.014995028	0.733379171	0.040554232	1.53E-10	0.002238438	0.127639879	5177.586543	1989.365377	7166.95192	-0.573	-0.353	0	1	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S085	CPT0063090003	C3N-00866	2	8	127N	C3N-00866-01	Tumor	No	C3N-00866	CPT0063090009	CPT0063090009.WholeExome.RP-1303.bam	1b01d1ea-eed0-4d42-903b-f811ba2ec579	Primary_Tumor	CPT0063210002	CPT0063210002.WholeExome.RP-1303.bam	5e2f889e-d261-442f-83bb-63f151bef53e	Blood_Derived_Normal	CPT0063090006	C3N-00866	Primary Tumor	99455b1b-f110-46ef-a03e-be651c28a0bd	170830_UNC31-K00269_0078_AHLCVMBBXX_TTAGGC_S8_L002_R1_001.fastq.gz	8323759d-cdc4-481c-8518-f170b5a87082	170830_UNC31-K00269_0078_AHLCVMBBXX_TTAGGC_S8_L002_R2_001.fastq.gz	C3N-00866	FIGO grade 1	Endometrioid carcinoma	4 or more	3	IA	under 50 %	Stage I	Yes	23.88	0	NA	77	0.141971235	0.001366269	0.020834183	0	0	0.254847613	0.017862528	0.029366632	0	0	0.028120711	0	0.017101616	0	0.016325308	0.163010063	0	0.74	0	0	0.034585703	0.01460814	0	0.006343461	0.074407637	0.020465846	0.746762428	0.043460088	4.41E-10	0.003497833	0.105062707	4333.723559	1380.859986	5714.583545	-0.6	0.533	0	1	0	0	0	1	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S086	CPT0078710004	C3N-00880	3	12	130N	"C3N-00880-01,C3N-00880-03,C3N-00880-04"	Tumor	No	C3N-00880	CPT0078710010	CPT0078710010.WholeExome.RP-1303.bam	104a6440-a2e3-4e92-b0af-ca129f694835	Primary_Tumor	CPT0078790002	CPT0078790002.WholeExome.RP-1303.bam	cd642219-843d-4989-94ed-ce830d8f76e7	Blood_Derived_Normal	CPT0078710007	C3N-00880	Primary Tumor	f0952653-8c23-4781-a477-c2ce76f9d1b6	170905_UNC31-K00269_0079_AHLCF7BBXX_GTCCGC_S5_L002_R1_001.fastq.gz	6a2bd4f3-68fc-48f2-a604-db2c5a7b665b	170905_UNC31-K00269_0079_AHLCF7BBXX_GTCCGC_S5_L002_R2_001.fastq.gz	C3N-00880	FIGO grade 2	Endometrioid carcinoma	1	3.2	IA	under 50 %	Stage I	No	27	0	0	61	0.080097796	0.017629382	0.019249438	0.005992563	0.039194685	0.184924122	0	0.002181305	0.046756746	0	0.034249071	0	0	0.012116224	0.011367262	0.03888996	0	0.5	0.0006	0	0	0	0.006719297	0.006020275	0.044698224	0.03431866	0.748925904	0.049057793	5.54E-09	0.004422598	0.112556539	5297.723765	2258.605402	7556.329167	0.589	0.63	0	1	0	1	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S087	CPT0078610003	C3N-01003	3	9	130N	C3N-01003-01	Tumor	No	C3N-01003	CPT0078610009	CPT0078610009.WholeExome.RP-1303.bam	a2ec9e6c-7905-4651-8f2f-dba4b20e994c	Primary_Tumor	CPT0078650002	CPT0078650002.WholeExome.RP-1303.bam	a78df87f-09cf-4552-b3a9-f9509699548e	Blood_Derived_Normal	CPT0078610006	C3N-01003	Primary Tumor	4313d974-189f-4e5e-93c5-87adb840c560	170830_UNC31-K00269_0078_AHLCVMBBXX_ATGTCA_S14_L006_R1_001.fastq.gz	a613938d-aa43-4c67-ba0c-78c1c6c69a7b	170830_UNC31-K00269_0078_AHLCVMBBXX_ATGTCA_S14_L006_R2_001.fastq.gz	C3N-01003	NA	NA	4 or more	3	IVB	50 % or more	Stage IV	Yes	31	0	NA	73	0.125676207	0.002885581	0	0	0.003210075	0.157008808	0.01803284	0.012636839	0	0.021980571	0.038248608	0	0	0.029239852	0.025906813	0.039094717	0	0.55	0	0.004320911	0	0.071758177	0	0.003476539	0.171853539	0.388840022	0.327989213	0.038687944	1.10E-07	0.003535598	0.065617035	4986.748413	4781.4706	9768.219013	0.745	1.15	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	MSS	WT	NA	normal
S088	CPT0075900003	C3N-01211	3	10	127N	C3N-01211-01	Tumor	No	C3N-01211	CPT0075900009	CPT0075900009.WholeExome.RP-1303.bam	328fa8fc-696f-4d47-828f-7cf2cd34df9e	Primary_Tumor	CPT0076020002	CPT0076020002.WholeExome.RP-1303.bam	bcea7d60-f004-48de-b990-f621f504d140	Blood_Derived_Normal	CPT0075900006	C3N-01211	Primary Tumor	420d5f06-1231-4f16-b090-9e27da0b3c83	170905_UNC31-K00269_0079_AHLCF7BBXX_GTGGCC_S8_L008_R1_001.fastq.gz	cc46aefa-d070-4531-b35b-69fef48f8fd4	170905_UNC31-K00269_0079_AHLCF7BBXX_GTGGCC_S8_L008_R2_001.fastq.gz	C3N-01211	FIGO grade 2	Endometrioid carcinoma	1	1.4	II	50 % or more	Stage II	No	39.2	1	NA	59	0.141429748	0.0004	0	0.005406991	0.03294438	0.138981912	0.013967784	0	0.062999837	0.00875642	0.024638292	0	0	0.00339234	0.053233302	0.03011827	0	0.53	0	0	0	0	0.01372593	0.002510216	0.085395952	0.094950229	0.716911368	0.025750294	6.72E-10	0.002150148	0.072331793	4308.368448	3118.051953	7426.420402	-2.29	-1.43	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S089	CPT0075380003	C3N-01212	2	6	130N	C3N-01212-03	Tumor	No	C3N-01212	CPT0075380009	CPT0075380009.WholeExome.RP-1303.bam	b9c5038e-63ba-4d53-8634-720518abd60b	Primary_Tumor	CPT0075440002	CPT0075440002.WholeExome.RP-1303.bam	64fc0220-163a-4cfe-b176-8a23a2bd8880	Blood_Derived_Normal	CPT0075380006	C3N-01212	Primary Tumor	77cb79fc-c379-49ee-a61a-861b047a8d63	170905_UNC31-K00269_0079_AHLCF7BBXX_GTCCGC_S5_L008_R1_001.fastq.gz	70834e25-c655-4715-a7f8-57741576d457	170905_UNC31-K00269_0079_AHLCF7BBXX_GTCCGC_S5_L008_R2_001.fastq.gz	C3N-01212	FIGO grade 2	Endometrioid carcinoma	2	1.5	IIIA	under 50 %	Stage III	No	30.48	1	NA	63	0.134138183	0	0	0.041876884	0.034536967	0.060843228	0	0	0.074846217	0.022408764	0.05131453	0.001489306	0	0.059210761	0.069264334	0.090537458	0	0.75	0	0	0.0008	0	0.108706228	0.00437853	0.084042172	0.057148988	0.713392309	0.023855996	7.00E-10	0.003461457	0.113720547	5583.319319	2514.266274	8097.585593	-1.17	-0.914	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S090	CPT0076500003	C3N-01217	2	7	130N	C3N-01217-01	Tumor	No	C3N-01217	CPT0076500006	CPT0076500006.WholeExome.RP-1303.bam	a87a69f6-fc98-4521-935d-1f922bfd72af	Primary_Tumor	CPT0076580002	CPT0076580002.WholeExome.RP-1303.bam	d2c55ed8-a5af-40b4-87f2-769084ef8832	Blood_Derived_Normal	CPT0076500009	C3N-01217	Primary Tumor	e60a5351-d5bd-4e4c-b9d2-64fcdca999b1	170906_UNC32-K00270_0058_BHLJ7FBBXX_GCCAAT_S22_L006_R1_001.fastq.gz	03100748-7dc8-4f11-a46f-9153d3769556	170906_UNC32-K00270_0058_BHLJ7FBBXX_GCCAAT_S22_L006_R2_001.fastq.gz	C3N-01217	FIGO grade 1	Endometrioid carcinoma	None	0.8	IB	50 % or more	Stage I	No	36.2	0	0	58	0.113462274	0	0.012461263	0	0.004096005	0.193189949	0.009557828	0.039610944	0	0	0.019183604	0	0	0.049541359	0	0.038721394	0	0.51	0.001268082	0	0	0.026629608	0.00227769	0.005318682	0.084442983	0.104628581	0.648440744	0.063668402	1.81E-09	0.002557199	0.090943407	4241.500932	4181.890175	8423.391107	0.994	0.474	0	1	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S091	CPT0076160003	C3N-01219	3	12	128C	C3N-01219-03	Tumor	No	C3N-01219	CPT0076160006	CPT0076160006.WholeExome.RP-1303.bam	562fe4a5-c4e2-4798-81b0-1f62f64e967a	Primary_Tumor	CPT0076220002	CPT0076220002.WholeExome.RP-1303.bam	177e63f2-7620-4c1d-8b8d-423880ed4f7a	Blood_Derived_Normal	CPT0076160009	C3N-01219	Primary Tumor	e20212d2-8826-470e-8ea9-fd482194e637	170906_UNC32-K00270_0058_BHLJ7FBBXX_ACAGTG_S23_L006_R1_001.fastq.gz	4411b385-dfc9-42a7-b200-a2ef23950c1e	170906_UNC32-K00270_0058_BHLJ7FBBXX_ACAGTG_S23_L006_R2_001.fastq.gz	C3N-01219	FIGO grade 3	Endometrioid carcinoma	1	5	IIIA	under 50 %	Stage III	No	26.14	0	NA	58	0.173192267	0.021208229	0	0	0.20547773	0.307954382	0	0	0.181109898	0	0.036010774	0.031665751	0.009145218	0.014336444	0.104941128	0.264904483	0	1.63	0	0.265176591	0	0.014877105	0	0.007294917	0.076176778	0.035342991	0.658669918	0.052033662	2.82E-08	0.009797105	0.160684601	8247.18979	3607.302476	11854.49227	-0.674	0.387	0	1	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	MSI-H	WT	Endometrioid carcinoma	normal
S092	CPT0027970003	C3N-01267	3	10	129C	C3N-01267-03	Tumor	No	C3N-01267	CPT0027970009	CPT0027970009.WholeExome.RP-1303.bam	1a29b2c3-51e2-409e-8e3d-d6ac729b1873	Primary_Tumor	CPT0028110002	CPT0028110002.WholeExome.RP-1303.bam	a34f5976-b993-4ecf-b10e-b087dc50dfd7	Blood_Derived_Normal	CPT0027970006	C3N-01267	Primary Tumor	63431135-a82e-4a29-a17d-70ca5b7def70	170912_UNC31-K00269_0081_AHL3YKBBXX_ATGTCA_S18_L005_R1_001.fastq.gz	a09574f4-c3e1-428c-a8a0-412950a3872a	170912_UNC31-K00269_0081_AHL3YKBBXX_ATGTCA_S18_L005_R2_001.fastq.gz	C3N-01267	FIGO grade 2	Endometrioid carcinoma	2	1.2	IIIC1	50 % or more	Stage III	No	30.85	1	NA	57	0.208514252	0	0	0	0.007875625	0.162633253	0.00602792	0.006748859	0	0	0.02334588	0	0.0019259	0.012271592	0	0.034484496	0	0.52	0.007400155	0	0.011965047	0.036807022	0	0.003797846	0.178905676	0.077860922	0.609733834	0.035186068	1.90E-08	0.002576266	0.091939368	4751.649418	4265.396681	9017.046099	-0.656	-0.506	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S093	CPT0116550004	C3N-01346	4	13	127N	"C3N-01346-03,C3N-01346-04"	Tumor	No	C3N-01346	CPT0116550007	CPT0116550007.WholeExome.RP-1303.bam	fdca91d2-25b0-4f76-857c-db178c70dbfd	Primary_Tumor	CPT0116610002	CPT0116610002.WholeExome.RP-1303.bam	008f12f6-e262-4f69-821d-32f09c4a56fe	Blood_Derived_Normal	RNAseq_C3N-01346_primary_tumor	C3N-01346	Primary Tumor	e471cc71-0f0b-421b-a1fb-40136d957698	180502_UNC32-K00270_0094_BHTVLMBBXX_CAGATC_S11_L003_R1_001.fastq.gz	05f8cd15-4e8b-4bc0-abb9-86024f30587e	180502_UNC32-K00270_0094_BHTVLMBBXX_CAGATC_S11_L003_R2_001.fastq.gz	NA	NA	Serous carcinoma	1	5.5	IIIC2	50 % or more	Stage III	NA	34	1	NA	63	0.14099011	0.019213128	0.025438194	0	0.088930214	0.26555035	0	0.015829072	0.101667828	0.003670969	0.029795527	0.002679818	0	0.029677669	0.081837455	0.085321157	0	0.92	0.016439373	0	0	0.012959135	0	0.006765475	0.085797165	0.12302872	0.636110127	0.031112939	7.83E-09	0.00826782	0.108917746	7726.246196	4617.267994	12343.51419	-2.52	-0.227	0	0	0	0	0	0	0	1	0	1	0	1	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S094	CPT0116630003	C3N-01349	4	14	127N	C3N-01349-02	Tumor	No	C3N-01349	CPT0116630006	CPT0116630006.WholeExome.RP-1303.bam	4b1d20a1-9201-493b-8b52-441b0a864589	Primary_Tumor	CPT0116700002	CPT0116700002.WholeExome.RP-1303.bam	74985518-2c76-4279-8ada-4b1752610b06	Blood_Derived_Normal	RNAseq_C3N-01349_primary_tumor	C3N-01349	Primary Tumor	61da9b88-7482-4b7a-8e66-275ecf12ceaf	180502_UNC32-K00270_0094_BHTVLMBBXX_ACTTGA_S10_L003_R1_001.fastq.gz	c23d4640-ab47-475d-9805-92cabdd16f22	180502_UNC32-K00270_0094_BHTVLMBBXX_ACTTGA_S10_L003_R2_001.fastq.gz	NA	NA	Serous carcinoma	4 or more	5	IB	50 % or more	Stage I	Yes	31	1	NA	77	0.031092652	0	0.017676251	0.044460701	0.052855743	0.176413766	0.029581456	0	0.207247911	0	0.066840911	0	0.040723911	0.026971786	0.036809347	0.063511306	0	0.81	0	0.004317008	0	0	0.01149725	0.009739342	0.084138822	0.037214567	0.720485921	0.026449078	8.09E-10	0.010901218	0.111071052	7310.646586	3784.055606	11094.70219	-1.68	-0.753	0	0	0	0	0	0	0	0	1	1	0	1	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S095	CPT0079650003	C3N-01510	4	14	131	C3N-01510-02	Tumor	No	C3N-01510	CPT0079650009	CPT0079650009.WholeExome.RP-1303.bam	7ac90e00-bd10-44e5-91f1-4e51b1764945	Primary_Tumor	CPT0080750002	CPT0080750002.WholeExome.RP-1303.bam	aa51f274-accb-4897-b533-cfd29ab5bd6a	Blood_Derived_Normal	CPT0079650006	C3N-01510	Primary Tumor	9c598e26-c32b-4405-af2a-c560941fb81a	170906_UNC32-K00270_0058_BHLJ7FBBXX_AGTCAA_S15_L004_R1_001.fastq.gz	086afb47-3e44-4075-900f-c9efeb622959	170906_UNC32-K00270_0058_BHLJ7FBBXX_AGTCAA_S15_L004_R2_001.fastq.gz	C3N-01510	FIGO grade 2	Endometrioid carcinoma	None	8.5	II	50 % or more	Stage II	Yes	40.72	1	NA	53	0.074485955	0	0	0.022511308	0.00889596	0.137475272	0.012682978	0.003415035	0.01575249	0	0.002659192	0	0	0.019304946	0.045953357	0.073887376	0	0.46	0.002005813	0	0.003062666	0	0.037907652	0.004837211	0.06940191	0.024165291	0.766422598	0.043054277	3.05E-09	0.002293855	0.089824854	4373.982627	1445.656243	5819.638871	-0.909	-0.208	0	0	0	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S096	CPT0076860003	C3N-01520	3	12	129N	C3N-01520-01	Tumor	No	C3N-01520	CPT0076860009	CPT0076860009.WholeExome.RP-1303.bam	42f49422-4ff7-43f6-9184-ebd29296debb	Primary_Tumor	CPT0076940002	CPT0076940002.WholeExome.RP-1303.bam	c55d1518-f131-4269-88df-57584fe2c37e	Blood_Derived_Normal	CPT0076860006	C3N-01520	Primary Tumor	a43b1b15-3b59-4e11-b589-8d89b7e63209	170830_UNC31-K00269_0078_AHLCVMBBXX_GCCAAT_S2_L007_R1_001.fastq.gz	b3135f8c-5c50-41a8-ae39-a427c93a993f	170830_UNC31-K00269_0078_AHLCVMBBXX_GCCAAT_S2_L007_R2_001.fastq.gz	C3N-01520	FIGO grade 2	Endometrioid carcinoma	2	1	IA	under 50 %	Stage I	No	29.37	0	0	69	0.098306727	0	0	0.008455565	0.059493274	0.158603661	0	0	0.063996724	0	0.027449986	0.065220541	0	0.058648319	0.063741986	0.066290344	0	0.79	0	0.070019705	0	0	0.049773167	0.007382878	0.077794978	0.035083294	0.693145404	0.04943904	9.11E-08	0.003529352	0.133624962	6104.870732	2659.994806	8764.865538	0.673	-0.595	0	1	0	1	0	0	1	0	1	1	1	1	1	0	0	1	1	1	0	MSI-H	WT	Endometrioid carcinoma	normal
S097	CPT0076680003	C3N-01521	4	14	128C	C3N-01521-01	Tumor	No	C3N-01521	CPT0076680009	CPT0076680009.WholeExome.RP-1303.bam	2337201b-200c-4135-ab99-f982407546ee	Primary_Tumor	CPT0076760002	CPT0076760002.WholeExome.RP-1303.bam	680b963a-9f31-450b-b00d-14ecf777079d	Blood_Derived_Normal	CPT0076680006	C3N-01521	Primary Tumor	0acc093f-71f7-4f80-a9b2-20e017cbd7e4	170830_UNC31-K00269_0078_AHLCVMBBXX_ACAGTG_S3_L007_R1_001.fastq.gz	1b05444d-acbf-4aa3-9981-0803c58db907	170830_UNC31-K00269_0078_AHLCVMBBXX_ACAGTG_S3_L007_R2_001.fastq.gz	C3N-01521	FIGO grade 3	Endometrioid carcinoma	2	4.2	IA	under 50 %	Stage I	No	29.4	0	NA	75	0.071179987	0	0.02562487	0.019512128	0.042764415	0.095607114	0.043358278	0.011821109	0.063638898	0.01763236	0.008318946	0	0	0.007080589	0	0.06592389	0	0.59	0	0	0.034393768	0.083143647	0	0.004994598	0.098499307	0.035242686	0.739457081	0.031691155	2.82E-07	0.005015088	0.085099802	5789.410018	2795.977059	8585.387077	-0.307	-0.342	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Endometrioid carcinoma	normal
S098	CPT0097010003	C3N-01537	4	13	129C	C3N-01537-01	Tumor	No	C3N-01537	CPT0097010009	CPT0097010009.WholeExome.RP-1303.bam	fc511a09-fb95-46c1-bae3-bea2b6a7ecc2	Primary_Tumor	CPT0097050002	CPT0097050002.WholeExome.RP-1303.bam	e0ecebcc-1693-4311-abda-f4b80b390f9a	Blood_Derived_Normal	CPT0097010006	C3N-01537	Primary Tumor	c00f784d-3143-4e88-b652-40a42aa38f53	171107_UNC32-K00270_0063_BHLNTCBBXX_CAGATC_S60_L007_R1_001.fastq.gz	53445ea6-98ca-4134-a8bb-cd64497935a7	171107_UNC32-K00270_0063_BHLNTCBBXX_CAGATC_S60_L007_R2_001.fastq.gz	C3N-01537	NA	Serous carcinoma	1	1.5	II	50 % or more	Stage II	No	35.42	0	NA	74	0.239386292	0	0	0	0.207608597	0.390061502	0	0	0.166271953	0.045215956	0.047962053	0.049980042	0.00180072	0.024315518	0.139580503	0.143705494	0	1.49	0	0.029759765	0	0.004351604	0	0.014872008	0.064904537	0.036505622	0.645013579	0.033524424	1.49E-09	0.010912287	0.194267542	9113.414303	4336.999577	13450.41388	-1.19	-0.324	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	MSS	WT	Serous carcinoma	normal
S099	CPT0080030003	C3N-01802	4	16	128C	C3N-01802-01	Tumor	No	C3N-01802	CPT0080030009	CPT0080030009.WholeExome.RP-1303.bam	8a4b482d-4bfb-4bc6-b38a-36632e59aed4	Primary_Tumor	CPT0080810002	CPT0080810002.WholeExome.RP-1303.bam	4f0aba5e-8b80-4c64-a93f-ac201bc23ebe	Blood_Derived_Normal	CPT0080030006	C3N-01802	Primary Tumor	06944ccc-05d4-42d9-917f-3e3e86355149	170906_UNC32-K00270_0058_BHLJ7FBBXX_CCGTCC_S16_L004_R1_001.fastq.gz	6820bed8-165e-49af-bfeb-3cd127060651	170906_UNC32-K00270_0058_BHLJ7FBBXX_CCGTCC_S16_L004_R2_001.fastq.gz	C3N-01802	NA	Serous carcinoma	1	3.8	II	under 50 %	Stage II	Yes	24.32	1	NA	85	0.125632435	0.00549566	0	0.047270477	0.099728201	0.145488511	0	0.023056066	0.056808071	0.003029268	0	0.275833718	0	0.038323966	0	0.24395747	0	1.21	0.021394706	0	0.065210688	0	0.058770763	0.009022295	0.069009999	0.056699664	0.63475045	5.12E-08	4.80E-09	0.008491865	0.22202567	8568.337599	4822.4358	13390.7734	-2.6	-0.939	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S100	CPT0097710003	C3N-01825	3	10	129N	C3N-01825-01	Tumor	No	C3N-01825	CPT0097710009	CPT0097710009.WholeExome.RP-1303.bam	dc05be9d-0e08-4235-87a0-f88fbf139422	Primary_Tumor	CPT0097750002	CPT0097750002.WholeExome.RP-1303.bam	75503034-28e8-4297-b2b3-095730e2b53a	Blood_Derived_Normal	CPT0097710006	C3N-01825	Primary Tumor	fb6e7290-6e05-40fd-b122-340633db8e34	171107_UNC32-K00270_0063_BHLNTCBBXX_TAGCTT_S56_L006_R1_001.fastq.gz	ee34816a-0060-45f6-9813-334207970349	171107_UNC32-K00270_0063_BHLNTCBBXX_TAGCTT_S56_L006_R2_001.fastq.gz	C3N-01825	NA	Serous carcinoma	NA	5	IA	under 50 %	Stage I	No	34.06	0	NA	70	0.187681071	0	0	0.022128812	0.064693237	0.22904602	0	0	0.430658443	0.058010582	0.003258252	0	0	0.064580904	0.05056075	0.030642108	0	1.19	0	0.0006	0	0.042631692	0.005492839	0.004767503	0.184282336	0.237164751	0.451561854	0.028463459	7.00E-09	0.004165019	0.089595072	6081.794155	5933.572259	12015.36641	-1.66	-0.976	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	1	0	0	0	MSS	WT	Serous carcinoma	normal
S101	CPT0001470001	C3L-00006	2	5	128C	C3L-00006-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-00006_adjacent_normal	C3L-00006	Solid Tissue Normal	caea5e0c-f3be-4db4-8837-c3f5d89ac4a6	180313_UNC32-K00270_0085_BHT2MGBBXX_CCGTCC_S39_L007_R1_001.fastq.gz	d5b2b761-e82a-4829-8aab-a78d87cde2a1	180313_UNC32-K00270_0085_BHT2MGBBXX_CCGTCC_S39_L007_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S102	CPT0002450001	C3L-00361	1	2	127N	C3L-00361-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-00361_adjacent_normal	C3L-00361	Solid Tissue Normal	2bb0bf8f-ed23-4cc6-aaa6-f36f1d0811ab	180109_UNC31-K00269_0107_AHNHY2BBXX_TTAGGC_S5_L002_R1_001.fastq.gz	6c30343e-37cb-40c2-898e-44c3125b5afd	180109_UNC31-K00269_0107_AHNHY2BBXX_TTAGGC_S5_L002_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S103	CPT0023640001	C3L-00586	2	6	129N	C3L-00586-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-00586_adjacent_normal	C3L-00586	Solid Tissue Normal	52d135b5-6065-44c4-abc4-8245ce9694dd	180109_UNC31-K00269_0107_AHNHY2BBXX_GCCAAT_S7_L002_R1_001.fastq.gz	9509bda6-905c-4583-b31a-debc0d5afc82	180109_UNC31-K00269_0107_AHNHY2BBXX_GCCAAT_S7_L002_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S104	CPT0007660001	C3L-00601	2	6	127N	C3L-00601-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-00601_adjacent_normal	C3L-00601	Solid Tissue Normal	15a20d32-beec-4388-9408-480db8a1ae5c	180109_UNC31-K00269_0107_AHNHY2BBXX_ACAGTG_S1_L002_R1_001.fastq.gz	0a6f5a3c-53aa-41bc-8c68-7292e1e6b059	180109_UNC31-K00269_0107_AHNHY2BBXX_ACAGTG_S1_L002_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S105	CPT0026540001	C3L-00769	2	5	129C	C3L-00769-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S106	CPT0027020001	C3L-00930	2	7	129C	C3L-00930-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S107	CPT0027130001	C3L-00932	2	8	128N	C3L-00932-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-00932_adjacent_normal	C3L-00932	Solid Tissue Normal	db54b077-a421-4528-9067-5fdc52ee5366	180109_UNC31-K00269_0107_AHNHY2BBXX_ACAGTG_S1_L001_R1_001.fastq.gz	1d2625d3-cb72-4722-aee4-b522a30139e0	180109_UNC31-K00269_0107_AHNHY2BBXX_ACAGTG_S1_L001_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S108	CPT0027430001	C3L-00947	1	1	129C	C3L-00947-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S109	CPT0016530001	C3L-00963	2	8	129N	C3L-00963-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S110	CPT0080990001	C3L-01246	2	7	127C	C3L-01246-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S111	CPT0080890001	C3L-01249	1	2	128N	C3L-01249-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S112	CPT0080620001	C3L-01252	1	1	128N	C3L-01252-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S113	CPT0073460001	C3L-01256	1	3	129N	C3L-01256-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S114	CPT0073530001	C3L-01257	2	7	128C	C3L-01257-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S115	CPT0077660001	C3L-01282	1	4	128N	C3L-01282-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-01282_adjacent_normal	C3L-01282	Solid Tissue Normal	b75aa815-18fc-4f67-8bd8-e80d70bf58d7	180109_UNC31-K00269_0107_AHNHY2BBXX_CGATGT_S10_L003_R1_001.fastq.gz	6c986f25-4352-4b8d-9f37-2de28762849a	180109_UNC31-K00269_0107_AHNHY2BBXX_CGATGT_S10_L003_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S116	CPT0064240001	C3L-01304	1	4	129N	C3L-01304-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-01304_adjacent_normal	C3L-01304	Solid Tissue Normal	fb12c9f3-e9e4-4234-b1ea-b652ea9e064d	180109_UNC31-K00269_0107_AHNHY2BBXX_CAGATC_S3_L001_R1_001.fastq.gz	9272b657-6b27-4628-adff-898271064f68	180109_UNC31-K00269_0107_AHNHY2BBXX_CAGATC_S3_L001_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S117	CPT0064320001	C3L-01307	1	4	127N	C3L-01307-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-01307_adjacent_normal	C3L-01307	Solid Tissue Normal	636ef258-acbd-443f-99c4-8966ebf303af	180109_UNC31-K00269_0107_AHNHY2BBXX_ACTTGA_S2_L001_R1_001.fastq.gz	8b68efdb-23b2-4936-8426-1d26933f64a5	180109_UNC31-K00269_0107_AHNHY2BBXX_ACTTGA_S2_L001_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S118	CPT0077780001	C3L-01311	1	3	128C	C3L-01311-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3L-01311_adjacent_normal	C3L-01311	Solid Tissue Normal	46a9c137-590c-40f8-83a9-848a8d0437a5	180109_UNC31-K00269_0107_AHNHY2BBXX_TGACCA_S6_L002_R1_001.fastq.gz	7bcd0306-0e63-4202-88b1-1ed2497e3547	180109_UNC31-K00269_0107_AHNHY2BBXX_TGACCA_S6_L002_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S119	CPT0093290000	C3L-01744	1	3	127C	C3L-01744-02	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S120	CPT0011020003	C3N-00333	2	5	127C	C3N-00333-07	Adjacent_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	CPT0011020005	C3N-00333	Solid Tissue Normal	3b0cb9d5-e735-43db-81bc-dd41c5404e88	171215_UNC32-K00270_0073_BHN3NFBBXX_CCGTCC_S5_L002_R1_001.fastq.gz	2e65e11f-f0c6-43e1-a97f-42beb6bcf2e9	171215_UNC32-K00270_0073_BHN3NFBBXX_CCGTCC_S5_L002_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S121	CPT0022850001	C3N-00383	1	2	129C	C3N-00383-06	Adjacent_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3N-00383_adjacent_normal	C3N-00383	Solid Tissue Normal	d8fdcaab-a8eb-452b-85d3-4e8342a5aa06	180313_UNC32-K00270_0085_BHT2MGBBXX_AGTCAA_S42_L008_R1_001.fastq.gz	edbf898c-dc38-48e4-b61b-09f11115d61e	180313_UNC32-K00270_0085_BHT2MGBBXX_AGTCAA_S42_L008_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S122	CPT0064950001	C3N-00729	2	6	128N	C3N-00729-06	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S123	CPT0078360001	C3N-00858	1	1	127C	C3N-00858-05	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3N-00858_adjacent_normal	C3N-00858	Solid Tissue Normal	2bb35dfa-8915-4f44-a7f3-309bee055f37	180313_UNC32-K00270_0085_BHT2MGBBXX_CTTGTA_S41_L008_R1_001.fastq.gz	c3a727a2-3121-46f4-8640-749db0e909dc	180313_UNC32-K00270_0085_BHT2MGBBXX_CTTGTA_S41_L008_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S124	CPT0063110001	C3N-00866	2	8	127C	C3N-00866-03	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	CPT0063110004	C3N-00866	Solid Tissue Normal	af76a34d-cc47-4d15-a276-60e3923b3975	171205_UNC32-K00270_0069_BHN2HGBBXX_ATCACG_S17_L005_R1_001.fastq.gz	335d84c6-609f-4669-ae8c-2242a24a4fa8	171205_UNC32-K00270_0069_BHN2HGBBXX_ATCACG_S17_L005_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S125	CPT0116570003	C3N-01346	4	13	127C	C3N-01346-05	Adjacent_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	RNAseq_C3N-01346_adjacent_normal	C3N-01346	Solid Tissue Normal	7f559a17-edd2-4465-aee8-61684540c52e	180516_UNC32-K00270_0095_AHTY5LBBXX_CGTACG_S5_L008_R1_001.fastq.gz	a2d046e8-2efb-4587-8ac7-fb8e6e340b40	180516_UNC32-K00270_0095_AHTY5LBBXX_CGTACG_S5_L008_R2_001.fastq.gz	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S126	CPT0191190002	C3L-03601a	4	16	127C	"C3L-03601-01,C3L-03601-02"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S127	CPT0191210002	C3L-03601b	4	16	128N	C3L-03601-03	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S128	CPT0182890003	C3N-03320	4	14	127C	"C3N-03320-01,C3N-03320-03"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S129	CPT0182950002	C3N-03411	4	13	128C	"C3N-03411-01,C3N-03411-02"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S130	CPT0189160002	C3N-03691a	4	13	128N	C3N-03691-01	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S131	CPT0189170002	C3N-03691b	4	15	128N	"C3N-03691-02,C3N-03691-03"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S132	CPT0189520002	C3N-03692	4	15	127C	"C3N-03692-01,C3N-03692-02,C3N-03692-03"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S133	CPT0183020002	NM_Mix1	4	15	131	"C3N-03412-02,C3N-03413-01,C3N-03413-03,C3L-03564-01,C3N-03692-02"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S134	CPT0191260002	NM_Mix2	4	14	128N	"C3N-03692-01,C3L-03602-02,C3L-03602-03,C3L-03563-01,C3L-03567-01"	Enriched_normal	Yes	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S135	CPT0063260001	C3L-00563	3	11	128C	C3L-00563-06	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S136	CPT0063900001	C3L-00605	3	12	127C	C3L-00605-06	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S137	CPT0026660001	C3L-00770	3	9	127C	C3L-00770-02	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S138	CPT0026780001	C3L-00771	3	11	127C	C3L-00771-02	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S139	CPT0017930001	C3N-00200	3	9	128C	C3N-00200-06	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S140	CPT0075940001	C3N-01211	3	10	127C	C3N-01211-06	Myometrium_normal	No	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
